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DEFITION OF TERMS 
Visual impairment in this context is defined according to classification of WHO for 
visual impairment, where is defined as all individual who have any form of visual 
impairment accounted for Snellen’s visual acuity of 6/24 or less. Therefore, people who 
are blind are included in this group of visual impairment. 
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ABSTRACT 
 
PREVALENCE, SEVERITY, RISK INDICATORS AND IMPACT OF VISUAL 
IMPAIRMENT AMONG DIABETIC PATIENTS IN MKURANGA DISTRICT, 
TANZANIA 
 
Emeritus Bugimbi Chibuga 
 
MPH Mini-Thesis, School of Public Health, University of the Western Cape 
 
INTRODUCTION 
 
Visual impairment is one of the major problems affecting diabetic patients worldwide. 
This problem is preventable if appropriate measures are taken early. Socio-economic 
consequences of this problem are significant especially in developing countries, since the 
treatment of diabetes mellitus is expensive and requires close monitoring. In fact, the 
management of diabetes mellitus is much more successful when the public health 
measures such as screening and health education aimed at raising diabetic awareness are 
effectively undertaken. Generally, prompt management of any ocular problem identified 
helps to reduce the burden of visual impairment among diabetics, and yet visual 
impairment remains a common complication of diabetes mellitus. Knowledge of the 
epidemiology and the burden of this co-morbidity (visual impairments and diabetes 
mellitus) in Mkuranga district is needed to inform appropriate interventions 
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AIM AND OBJECTIVES 
 
To determine the prevalence, severity and risk indicators of visual impairment among 
diabetic patients attending Mkuranga district hospital, and to evaluate its impacts on their 
activities of daily living and socio-economical consequences encountered by diabetic 
population with visual impairment as compared to those with normal vision.  
 
METHODS 
 
Quantitative cross-sectional descriptive and analytical study of all diabetic patients 
attended the diabetic clinic in Mkuranga District Hospital between August 2012 and 
October 2012. 
 
Data collection: Structured questionnaires were used as a tool for data collection 
regarding the prevalence, severity, risk indicators and impact of visual impairment among 
diabetic patients. 
  
Data analysis: Data were entered in coded form and later analysed using Epi Info 2000 
software.  
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RESULTS 
 
Prevalence of visual impairment among diabetic patients attending Mkuranga District 
Hospital was found to be 23.3%, with males had a higher prevalence than females (27.0% 
and 19.9% respectively).  The cause of visual impairment was predominantly retinopathy 
(50.0%) and cataract (17.1%). The risk indicators for visual impairment identified were 
duration of DM (p-value less than 0.05).  Visual impairment was noted to have a greater 
impact for activities of daily living and quality of life. 
 
DISCUSSION 
 
The prevalence of visual impairment in the study area was found to be within the African 
range; however, it was slightly higher than predicted before the beginning of the study. 
Glycemic control had no association with visual impairment. 
Poor attendance for eye-examination was due to lack of knowledge.  Women were given 
low priority in access to eye-care and knowledge regarding diabetes mellitus. 
 
 
 
 
 
CONCLUSION AND RECOMMENDATIONS 
 
 
 
 
 
 xiv 
Dealing with the management of eye complications due to diabetes is not the best option 
in developing countries due to scarce financial resources and inadequate eye health/care 
providers. 
The best way of dealing with such problem, therefore, is early case detection and 
identification of complications at an earlier stage through screening especially by using 
trained village or local health workers. Thus, public health approach towards the 
prevention or elimination of risk factors will be successful only if it is incorporated in the 
district health plan and budget, which will then focus on the identification of high risk 
case and intervention in high risk groups through community health education. Moreover, 
it should pay close attention to non-communicable diseases, health policies and practices 
by appropriate integration of this programme in health practices system. 
 
 
 
 
 
 
 
 
 
  
 
 
 1 
 
CHAPTER ONE 
 
INTRODUCTION 
 
1.1. Background and rationale  
Diabetes mellitus (DM) is a group of metabolic disease, whose main feature is high blood 
sugar (Molleutze and Levitt, 2006). The high blood sugar is caused by deficiency of 
insulin production, insulin action or both (National Institute of Health, 2011). DM is 
classified as a non-communicable disease (NCD). NCDs constitute a group of diseases 
that gets special attention in the global health care because the prevalence of individual 
diseases is increasing and another factor is their silent nature, but significant long-term 
fatality rates (Boutayeb and Boutayeb., 2005, Chand, 2012). There are two main types of 
DM: Type 1, which is insulin-dependent, and Type 2, which is referred to as insulin-
independent DM. Gestational diabetes is an additive group noted to be related with 
pregnancy (Garratt et al., 2000, National Institute of Health, 2011). This disease can 
affect all ages, sexes, ethnicities and socio-economic groups (Ward and MacKinnon, 
1992).  
 
DM affects nearly 2–4% of the world’s population (King et al., 1998; Wild et al., 2004). 
One study, which was conducted in 91 different countries to calculate the age and sex 
specific DM prevalence, before being applied to national population estimates in 216 
countries to determine the prevalence, estimated that the global DM prevalence in 2010 
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would reach 6.4% (Shaw, Sicree and Zimmet, 2010). In Africa, it is estimated that about 
1% of the population is affected by this disease (Sobngwi et al., 2001). In future, the 
burden of DM in Africa is expected to rise and, if nothing changes, the burden of DM in 
developing countries will outnumber that of the developed countries (King et al., 1998). 
The long-term consequences of high blood sugar include damage to multiple organs and 
body systems such as the kidneys, cardio-vascular system, lower extremities, nervous 
system and the eyes. If DM is not well controlled, it may cause visual impairment with 
subsequent permanent blindness as one of severe complication. Visual impairment and 
blindness have a great impact on activities of daily living and the global economy in 
general, since it affects mostly the productive age population (Marshal & Flyvbjerg, 
2006; Ciulla et al., 2003). Although appropriate early management of diabetes mellitus 
has been found to control most diabetic complications (National Institute of Health, 
2011), many developing countries have not achieved effective mechanisms to control 
DM for various reasons. 
 
In Tanzania, the management of DM is a new emerging health challenge. It has been 
reported that there is a rapid increase in diabetic prevalence (Ramaiya, 2005, Mayige, 
Kagaruki, Ramaiya, Swai, 2012). In fact, it accounts for 4.0% of the urban population 
and 1.9% of the rural population. Initially, the prevalence was estimated to be around 
0.8% of the population. This rise was experienced within a short period (Ramaiya, 2005). 
Deliberate efforts have been made and kept in place to cope with the increasing number 
of diabetic patients. Through the Tanzania Diabetic Association (TDA) initiatives, 19 
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regional diabetic centres, open to all diabetic patients, were created. Services provided by 
these centres are subsidised by the government to make them affordable for all diabetic 
patients. These subsidised services also seek to reach the ever rising demand of diabetic 
patients seeking diabetic care. However, diabetic patients face challenges in utilising 
these centres, mainly because most of these centres are located in regional urban settings, 
hence limiting the access of people living in districts and rural areas (Ramaiya, 2005).  
Mkuranga district likely faces these challenges. However, the prevalence of DM and 
visual impairment within the district remains unknown due to the absence of appropriate 
data with which to determine the true burden of DM and visual impairment cases. From 
extrapolations, it is likely the burden of visual impairment in Mkuranga district is high 
when we do projection from a study which was conducted in close geographical 
proximity to Mkuranga district (Majaliwa et al., 2007). 
 
A large population of Mkuranga district lives in the rural areas (National Bureau of 
Statistics, 2005), and depends on subsistence farming and fishing as the source of making 
living. The majority of these Mkuranga residents earns less than 1 USD per day (Institute 
of Resource Assessment, 2005). This low income has a considerable socio-economic 
impact when it comes to the management of DM. 
 
 
1.2 Problem Statement:  
There are several problems within Mkuranga district that further hinder DM 
management. These include lack of drugs, diagnostic and monitoring tools as well as 
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scarce diabetic care specialists who can manage diabetic patients appropriately within the 
district. As a result, patients experience additional financial burden in terms of travelling 
costs which they encounter when they seek diabetic management from other regions. 
Since visual impairments are known complications of DM, knowledge of the 
epidemiology and burden of this co-morbidity with diabetes mellitus in Mkuranga district 
is needed to inform appropriate interventions. In order to establish a well and organised 
management programme for visual impairment in diabetics, we have to know the 
magnitude, risk factors for progression of visual impairment and facilities available to 
manage the DM. Such information is a key for establishing locally appropriate public 
health measures against DM within Mkuranga district. 
 
1.3 Aim and Objectives 
To determine the prevalence, severity and risk indicators of visual impairment among 
diabetic patients attending Mkuranga district hospital, and to evaluate its impacts on their 
activities of daily living and socio-economical consequences encountered by diabetic 
population with visual impairment as compared to those with normal vision.  
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CHAPTER TWO  
 
LITERATURE REVIEW 
 
Prevalence and burden of Diabetes Mellitus:  
 
The global prevalence of diagnosed diabetes mellitus is estimated to be between 2–4% 
(King et al., 1998; Wild et al., 2004). However, the true global burden of DM might be 
higher than predicted prevalence since a good number of patients with type 2 DM are yet 
to be diagnosed even in developed countries (Garratt et al.,  2000, National Institute of 
Health, 2011).  It is estimated that by the year 2030, there will be a two-fold increase in 
diabetic cases worldwide (Wild et al., 2004). These estimates assume that the risk factors 
for acquiring DM remain almost the same. There is however evidence indicating that the 
rate of urbanisation is increasing especially in developing countries (UN-HABITAT, 
2010, United Nations, 2004). The UN-HABITAT report (2010) showed that cities in 
Eastern Africa have had an annual urban growth rate of 3.86% which is higher than the 
global trend of 2.5%. Data exists in support of the fact that for the past 50 years, the 
population in Eastern Africa cities have risen from 6 million to over 77 millions in an 
exponential pattern, and if this pattern will be maintained, then the population in East 
African cities is projected to rise up to 116 million by the year 2020, and by the year 
2030, to be over 172 million. Most of people who migrate to urban areas acquire new 
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lifestyle which is characterised by significant dietary changes and lack of physical 
activity when compared to rural dwellers, this exposes them at an increased risk of 
acquiring DM (Mennen et al., 2000). For this factor, it seems there is an exponential 
increase in the risk factors for DM which may make the suggested doubling in the 
prevalence rates for 2030 to be under-estimated.  
 
Currently, developed countries are estimated to carry larger proportion of diabetic 
patients. A study in Australia revealed that they had higher prevalence than the global 
estimates where men had a diabetic prevalence of 8% while female had 6.8% (Dunstan et 
al., 2002). But situation might change in future, where the developing countries might 
carry the higher burden of DM, as King and his co-authors (1998) had made a projection 
that by the year 2025, the global burden of DM will increase by 42% in developed 
countries and by 170% in developing countries.  
 
Prevalence of DM in Africa is estimated to be 1–2% in rural and 1–13% in urban areas 
depending on risk factors among the population. Type 2 DM is a predominant type, 
accounting for 70–90% of all diabetic cases (Sobngwi et al., 2001). However, in reality, 
this prevalence does not reflect the actual burden of DM in Africa, and in particular, sub-
Saharan Africa (SSA). This is because, the referred prevalence rates were obtained from 
studies conducted in few countries and subsequent results obtained were projected to 
other countries depending on their geographical proximities, ethnical background and 
socio-economic parameters (Wild et al., 2004). The methodologies used in these studies 
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were different, and in addition, the prevalence obtained from respective studies was based 
on different contextual assumptions. In some studies, assumptions were made that the 
prevalence of DM in rural areas were half of those obtained in their respective urban 
areas, whereas other studies made an assumption of a quarter of that obtained in urban 
and some even made a prediction of equal prevalence between urban and rural areas, thus 
leading to unanimously incomparable conclusions. A study conducted by Majaliwa and 
colleagues (2008) recognised that, the true burden of DM in SSA is unknown. Lewallen 
and Courtright (2001) when summing up their systematic review and meta-analysis of 
epidemiological estimates on the burden of blindness in Africa especially that caused by 
effects of DM, averred that it was “safe to say that treatment of diabetes in Africa is poor 
and very few diabetics have access for treatment for retinopathy”. This is an indicative 
statement that the burden of blindness is unanimously bigger than what is known, and 
management is a big challenge which may increase the burden to the economic growth 
for developing countries. 
 
The situation of DM in Tanzania is similar to other developing countries, where the 
actual burden is not known due to limited studies which have been done to determine the 
magnitude of the problem. Few studies available show the prevalence of DM, and many 
years have elapsed since they were done, therefore studies presented do not give a true 
reflection. A study which was done in six villages in Tanzania revealed diabetic 
prevalence of 0.87% and impaired glucose tolerance test of 7.8% (McLarty et al., 1989). 
Another study was done in two different communities, it was found that for both men and 
women living in urban areas had a higher prevalence of diabetes, impaired fasting blood 
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glucose, overweight and were less active than those from the rural communities despite 
that they were done in different communities differing in many characters (Aspray et al., 
2000).  
 
Risk factors for Diabetes Mellitus:  
Longevity and increased urbanisation are among the factors hypothesised to contribute to 
the increase in DM prevalence (Gwatkin et al., 1999, Sudeep, 2012).  It has been found 
that people who live in urban areas have a higher prevalence of DM compared to those 
who live in rural areas (Sobngwi et al., 2001). The main reason for having an increased 
risk for developing DM is due to lifestyle changes associated with urbanisation. 
Similarly, rural set-up which is relatively more urbanised, has higher prevalence of DM 
as compared to less urbanised rural area, this finding was obtained from a study done in 
two communities of Cambodia the prevalence of diabetes was 11% in a more developed 
rural community as compared to 5% on a less developed community (King et al., 2005). 
Another interesting finding was that about two-thirds of studied population were not 
aware that they were diabetics. This finding gives a picture that, it is likely that the 
current global prevalence of DM might be under-estimated especially when case 
ascertainment for DM prevalence is based only on self-report.  
 
Knowledge related to DM in some of the developing countries is still low resulting in low 
or no attendance to health facilities for diabetic check-up, screening and management. 
Therefore, it is likely many undiagnosed diabetic patients are still at higher risk of 
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developing complications including visual impairment which projects increase in the 
burden of the diabetic complications in the developing world. 
 
Diabetes Mellitus and Visual Impairment:  
Visual impairment is one of the commonest problems faced by diabetics. Many diabetic 
patients live with some form of visual impairment (Williams, 2008). A cross-sectional 
study conducted in Oman to determine the magnitude and determinants of visual 
impairment among diabetics, had a main aim to identify additional risk factors for 
diabetics to develop visual impairment. The results of this study found that the prevalence 
of visual impairment was 28.4% among patients with DM. Other studies which were 
done in Ethiopia and South Africa investigating the burden of visual impairment among 
diabetics found the rate to be higher ranging from 36.8% - 84% (Teshome et al., 2004; 
Mash, et al., 2008). These points to a pervasive co-morbidity of DM and visual 
impairments especially when it is noted that in the study by Teshome and colleagues 
(2004), only problems related to the retina were considered rather than other causes of 
visual impairment. 
 
Majority of visual impairments in diabetic patients has been noted to be secondary to 
diabetic retinopathy (DR). There are some studies which investigated the diabetic-related 
ocular complications, whereby DR was found to be the leading cause of visual 
impairment. The rate of prevalence for diabetic retinopathy was found to range from 
9.2% to 55.4% (Levitt et al., 2004; Teshome et al., 2004; Mengesha, 2006; Gill et al., 
2008; Majaliwa et al., 2008). Some studies which were done in developed world had 
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contrary results for DR, where this condition was among the minor causes of visual 
impairment in diabetics (Delcourt et al., 1995, Prasad et al., 2001). 
 
Risk factors of Visual Impairment in DM:  
Poor glycemic control and duration of DM has been observed to be a risk factor for 
developing retinopathy, while diabetic retinopathy is the leading cause for developing 
visual impairment among diabetics. In an Ethiopian study which was done in two 
communities found these risk factors had an association with the development of 
retinopathy (Gill et al., 2008), similarly a study done in Nigeria shows the same 
relationship where high fasting blood sugar was found to carry a threefold increased risk 
of developing retinopathy when compared to low fasting blood sugar (Rotimi et al., 
2003), however, other risk factors were not measured in this study, which were important 
as well. A meta-analysis study which was done by clustering researches based on clinical 
course of DR, found that the duration of DM had an effect for the progression of DR 
(Wong et al, 2009). 
 
The Wisconsin population-based prospective cohort study (Klein et al., 1984) determined 
risk factors which pre-determine the progression of DR. They took a random sample of 
diabetic patients and investigated “pre-determining” risk factors. Among the risk factors 
identified which were related to progression of DR were increasing age, duration of DM, 
higher glycosylated haemoglobin and presence of cardiovascular problems such as 
hypertension. The same study population was followed by another study (Klein et al., 
2010) where newly adopted standard definition of visual impairment was used. Results of 
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factors carrying an increased risk for DR were similar to the initial study by Klein et al. 
(1984). Same findings of higher level of glycosylated haemoglobin (which indicates poor 
glycemic control) were obtained in other studies conducted in Denmark (Olivarius et al., 
2011), the Indian state of Andhra Pradesh (Krishnaiah et al., 2007) and Malawi (Cohen et 
al., 2010). 
 
In Tanzania, poor glycemic control which is known to be a risk factor for developing 
diabetic complications is still a problem. A study conducted among children and 
adolescents in Dar es Salaam found only 1% had a good glycemic control, while 60.6% 
had a moderate control and 14.1% poor control (Majaliwa et al., 2007). Diabetic eye 
complications are among the leading diabetic complications, prevalence of retinopathy 
was found to be 25% among all diabetic complications (Mhando and Yudkin, 1980), and 
again this is an old study which the situation might have changed today. 
 
Lack of awareness of DM and its complications among Tanzanians might be a 
contributing factor for late attendance to the hospitals, and therefore might be the factor 
contributing the development of complications. In 2004, a survey done in the Tanzania 
hospitals as reported by Ramaiya (2005) found that more than two-third of diabetic 
patients were not aware that their problem was related to different blood sugar levels. 
Similarly, the health care personnel were not well aware of the key aspects of diabetic 
diagnosis, treatment, complications and education for management. Therefore, it is not 
surprising that in a study conducted in Dar es Salaam (Majaliwa et al., 2007) found that 
75% of children and adolescent brought to the hospital, the first presentation was diabetic 
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keto-acidosis which is a serious complication after having very high uncontrolled blood 
sugar. Another study which was done in Kilimanjaro found only 28.8% of diabetic 
patients had their eye checked within the past 12 months, despite the hospital being well 
staffed and the eye department within the hospital being well equipped (Mumba et al., 
2008). The authors in this study concluded that the eye examination was improved to 
47% after intervention, but the study was conducted for six months, and it is possible that 
some of the patients might have just gone to have their eye checked because they were 
advised to go under the influence of that study. There is scope for anthropological 
investigations to further explore the reasons why patients do not go for eye examination. 
 
Cost of diabetic treatment might be another barrier, a study which was done in 
Kilimanjaro for cost analysis of diabetic management (Neuhann et al., 2002), showed 
that the cost was approximately 25% of the minimum monthly wage. This has a great 
impact for communities living below the world poverty line of earning less than 1 USD 
per day and might have relevance in Mkuranga where residents are poor and the cost of 
diabetic management might be high taking into account that majority live under 1 USD 
per day (Institute of Resource Assessment, 2005).  
 
Public health Impact of Visual Impairment in diabetic patients: 
Diabetic eye disease which is usually characterised by visual impairment is one of the 
major preventable public health problems (Stefánsson, 2006). The cost of treating 
diabetic complications has been reported in the WHO report as cited in Tesfaye and Gill 
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study (2011), that it accounts for 31% of all outpatient costs. Cost per person in a year 
was estimated to be 19 times more than the average cost. 
Visual impairment in DM has great effect on individual quality of life and global 
economy. It has been shown in an Indian study that diabetics are at higher risk of getting 
blindness which is 25 times more than the general population (Ward and MacKinnon, 
1992), and the most affected population is adults in the economically-productive age 
group (Marshal & Flyvbjerg, 2006; Ciulla et al., 2003). 
 
A South African study (Levitt et al., 2004), among blacks in Cape Town attending 
diabetic ambulatory clinics, apart from finding more than half of diabetics patients 
studied to have diabetic retinopathy, also it was discovered that most diabetic 
complications which patients presented with at mobile clinics were never recorded in 
their case notes for the past year prior to the study. They then concluded that it was a 
major deficit at primary level intervention which needed to be addressed. This is just an 
example of poor diabetic care in developing countries which predispose them to more 
diabetic complications, and thus, increase the unnoticed burden of this disease. 
Despite the above mentioned shortcomings, it has been shown that public health 
approaches in the management of DM have positive effects in reducing most preventable 
diabetic complications including retinopathy. Combined effort of ophthalmologists and 
public health specialists using the available technology plays a large role in the reduction 
of potential blinding diabetic complication. This is achieved by detection of complication 
and giving appropriate management at earliest stage. This can be largely achieved if 
appropriate diabetic knowledge is addressed to all diabetic patients at the community 
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level, so as to increase the knowledge related to diabetic complications and their 
management which will potentiate diabetic patients to have their eyes check regularly 
(Stefánsson, 2006). Diabetes Association of Greater Cleveland (DAGC) project named 
“Working Together for a Change”, was successful in diabetic educative approach in such 
a way they admitted that by working together with public health specialists, they were 
able to disseminate successfully the diabetic knowledge among the visually impaired 
diabetic patients which influenced their annual eye examination (Williams, 2008). 
Intervention using community-based programmes for early detection of diabetic eye 
disease which involves screening procedures has proven to reduce the rate and severity of 
diabetic eye disease (Agardh et al., 1993, National Institute of Health, 2011). Intensive 
treatment is another approach which has shown successes in reducing the rate of 
progression for visual impairment in diabetics (Diabetes Control and Complications Trial 
Research Group (DCCTRG), 1993). The DCCTRG in their conclusive statement, they 
admitted that their success in their study and management of diabetic patients was 
obtained through incorporation of both medical and non-medical specialists. 
 
In conclusion, there is a paucity of thorough and systematic investigations on visual 
impairment among diabetic patients in Mkuranga district in particular and Tanzania in 
general. In order to establish a well and organised management programme for visual 
impairment in diabetics, we have to know the magnitude, risk factors for progression of 
visual impairment and facilities available to manage the DM. Such information is a key 
for establishing locally appropriate public health measures against DM within Mkuranga 
district. 
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AIM AND OBJECTIVES: 
 
AIM 
To determine the prevalence, severity and risk indicators of visual impairment among 
diabetic patients attending Mkuranga district hospital, and to evaluate its impacts on their 
activities of daily living. 
 
OBJECTIVES 
1. To determine the prevalence of visual impairment among diabetics patients 
attending diabetic clinic in Mkuranga district hospital. 
2. To determine the severity of visual impairment among diabetics patients with 
visual  impairment attending diabetic clinic in Mkuranga district hospital 
3. To determine the risk indicators for visual impairment among diabetic patients 
with visual impairment attending diabetic clinic in Mkuranga district hospital. 
4. To determine the socio economical impact of visual impairment on the activities 
of daily living of diabetic patients with visual impairment compared to the 
diabetic patient without visual impairment attending diabetic clinic in Mkuranga 
district hospital.  
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CHAPTER THREE 
 
METHODS 
 
Study Area 
This study was done in Mkuranga District from August 2012 to October 2012. 
 
Study Population 
All diabetic patients attended the Mkuranga District Hospital from August 2012 to 
October 2012 were recruited after signing an informed consent for participating in the 
study 
Study design 
This was prospective cross sectional descriptive and analytical study of all diabetic 
patients attended the diabetic clinic at Mkuranga district hospital.  
 This study focused on quantifying the prevalence, severity, risk indicators of visual 
impairment and its impacts among diabetic patients attending diabetic clinic in Mkuranga 
district hospital. In addition, it explored the socio-economic challenges facing diabetics 
who had visual impairment and its consequences on activities of daily living. This was 
analysed and compared to those who had no visual impairment. 
 
Inclusion criteria 
All diabetic patients attending Mkuranga district hospital.  
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Exclusion Criteria: 
All diabetic patients who had any form of visual impairment, this includes those who 
were blind prior to the diagnosis of DM, but the cause is not related to diabetes. 
  
Sampling technique:   
All diabetic patients attending the Mkuranga District Hospital were recruited.  
For the determination of severity of visual impairment all diabetic patients found to have 
visual impairment were graded according to the WHO criteria for visual acuity and visual 
impairment. 
 
Sample size: 
The sample size was estimated at 196, which was calculated using the following formula: 
                   z
2
 
.
 p 
.
 (1-p)  
n    =     ------------------------- 
                          d
2
  
n   =        (1.96)
2
 x 0.5 (1-0.5)  
           __________________ 
                    0.07
2
 
                n = 196
 
Where: 
d = absolute precision = 0.07 
p = expected proportion in the population = 0.50 
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z(1-a/2) = 1.96 = value of the standard distribution corresponding to a significance 
level of a (1.96 for a 2-sided test at the 0.05 level)  
 
 
Data collection: 
Interviewer-administered questionnaire was used as the tool for data collection for all 
diabetic patients. Physical examination yielded information related to the level of visual 
acuity as a determinant and grading tool for visual impairment. Information regarding 
risk indicators was obtained through clinical, socio-demographic and interview data, 
where factors associated with visual impairment in diabetics were checked. 
Data to assess the impact of the visual impairment was obtained through information 
which was compared between visual acuity in relation to ability to work, psycho-social 
factors, cognitive functions and coping with management of the diabetic condition 
 
Data collection procedures: 
All data were collected after informed consent was signed by study participants.  Both 
demographic characteristics of all study participants and their results of fasting blood 
sugar level tested on the same day of interview were recorded. Visual acuity was tested 
by research assistants in a well illuminated area outside the examination office by using 
the Snellen’s E-chart which was kept at 6 meters away from the study subjects. The 
examination of anterior segment of the eye was done by ophthalmologist to all study 
participants. All the findings were recorded in the questionnaire and later coded.  
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Diabetic patients with visual impairment but no obvious anterior segment ocular 
pathology were refracted by trained ophthalmologist to rule out other confounding factors 
as the potential cause of visual impairment. 
Posterior segments of the eye were examined after fully dilating the pupil using 
tropicamide eye drops pre-mixed with epinephrine. Finally, interview was conducted by 
use of interviewer-administered questionnaire. 
 
Rigour:  
To ensure validity and reliability of data collected, training on the procedures of data 
collection was done to the study team prior to the commencement of the study. The study 
team comprised of the ophthalmic assistant officers, data entry operator, ophthalmic 
nurses and Ophthalmologists who had special training in refraction and retina (Retina 
specialist). A pilot study was done in a non-project health unit and all potential 
ambiguous questions were modified and data collection tool adjustments were made.  
All equipments that were used for this study were checked and tested before initiation of 
the fieldwork.  
Data obtained were coded on the same day by using numerical values, and then stored in 
a computer and memory data device to ensure data security. Missing data were traced 
back as soon as they were discovered to be missing and when the missed data was 
recovered, they were coded and recorded in the appropriate column of the study 
participant. Every Saturday, the data entered were cross checked to ensure consistency 
and to ensure that they were free of errors. All raw data were converted into electronic 
form by entering the codes on MS Excel spreadsheet in a computer at appropriate rows 
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and columns. To ensure reliability, a range of data checks were done, random check was 
done on 15% of raw data, and re-entry was done to check for accuracy. The final check 
was done and confirmed using the software which ensured that there were no 
inconsistencies or invalid data.  Manual data was checked for consistency to ensure that 
proper instruction was given to the computer. 
Back-up copies of data entered on daily basis were kept by data operator and principal 
investigator.  
 
Data Analysis:  
Data were entered, coded and analysed using Epi Info 2000 software.  
 
Study Limitation 
Recall bias was minimised especially when eliciting information regarding the duration 
of DM from the time of diagnosis, by which this information was useful on determining 
risk indicators. Categorisation for duration from the time when diagnosis of DM was 
simplified (see Appendix I for details) and reference with important event within the 
community or country were referred to capture the duration.  
Due to variation in geographical factors, economical power of different communities and 
availability of facilities for diabetic care, the results obtained from this study might not be 
possible to generalise in different settings within Tanzania. 
 
Ethical issuesBefore commencement of this study, the proposal was submitted to the 
UWC Research Ethics and Senate committees, Tanzania’s National Institute for Medical 
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Research (NIMR) and the Mkuranga district Hospital ethical committee and permission 
to conduct this study was given by all these authorities. Prospective participants were 
provided with information of the study (see Appendix II) which included a clear 
description of the aim of the study and that its primary intention for fulfilling the 
requirements for my Masters in Public Health degree. Furthermore, it was explained to 
them their rights to leave the study at any time or not participate in the study at all 
without necessarily explaining the reason for cessation from the study participation. An 
informed consent form (see Appendix III) was signed by the patients when they agreed to 
participate in the study.  
For the purpose of clarity, the data collection tool, participant information sheet and 
consent form were translated into Swahili language which is the native language spoken 
at the study area and Tanzania in general, and these has been attached as appendix IV, V 
and VI respectively. 
During the course of data handling, cleaning and analysis, only codes were used instead 
of names. All data were kept in lockable cabinets and computer which were accessible by 
the researchers only. 
For study participants who were detected to have any form of visual impairment or 
condition that needed further review or management, they were given referral letters to 
attend a tertiary unit for further management or were sent to local physician with an 
internal transfer note at the district hospital for appropriate management.  
Appropriate counseling was given to such patients before they were given their referral 
letters. 
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CHAPTER FOUR 
 
RESULTS 
 
4.1. Description of Study Sample:  
A total number of 165 diabetic patients were recruited during the study period from 
August 2012 to October 2012. Among them, 2 had to be removed from the study as the 
primary cause of visual impairment was not related to DM, therefore the final sample size 
taken was 163 giving a response rate of 83.2%. This was attributed to some extent by 
coincidental Ramadan fasting where the larger population of Mkuranga district are 
Moslems, therefore activities involving gatherings or long waiting time are not attended 
sufficiently. 
 
Male to female ratio was almost equal, male having an edge above female by a ratio of 
1.2:1 (Table 1). The age of study participants ranged from 23 to 70 years. The mean age 
of respondents was 52.2147 years (Standard deviation of 8.2923 years). Among the age 
groups, those between 41 to 60 years had a larger proportion of all diabetic cases 
recruited in the study accounting for 77.3% of the total study sample (Table 1). 
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Table 1: Frequency of Age groups and Gender (n=163) 
Age groups in years  Number of Males 
(%) 
Number of Females 
(%) 
Total (%) 
20 – 40 8 (9.0) 5 (6.8) 13 (10.0) 
41 - 60 64 (71.9) 62 (83.8) 126 (77.3) 
61 - 80 17 (19.1) 7 (9.5) 24 (14.7) 
Total 89 (100.0) 74 (100.0) 163 (100.0) 
 
 
Impaired blood sugar was observed in 74.2% of the study participants, in overall, 20.2% 
had very high blood sugar which needed prompt treatment (Table 2). This situation has in 
impact as far as diabetic eye complications are concerned. 
 
Table 2: Frequency of Fasting Blood Glucose level (n=163) 
Range in mg/dl Male Female Total (%) 
Below normal (Less than 
80) 
1 0 1 (0.6) 
Normal (80 – 140) 23 18 41 (25.2) 
Impaired (141 - 180) 48 40 88 (54.0) 
High (Above 180) 17 16 33 (20.2) 
Total 89 74 163 (100.0) 
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4.2. Prevalence of visual impairment:  
The prevalence of visual impairment among diabetic patients surveyed was found to be 
23.3%. However, for males, the prevalence of visual impairment was 27.0% and 19.9% 
for females as shown on Figure 4 below. Severity of visual impairment was graded 
according to WHO classification, those found to have moderate visual impairment, had a 
prevalence of 9.2% which was obtained from 15 diabetic patients. For severe visual 
impairment, the prevalence was 8.0% (13 study subjects) and for those who had very 
severe visual impairment (blind), had a prevalence of 6.1% which was obtained from 10 
study subjects. The remaining 125 study subjects (76.7%) were classified as a group of 
individuals with normal vision. Details are shown in Table 3 below. 
 
Table 3: Classification of Visual Acuity (n=163) 
Classification of Visual acuity Male Female Total Percentage 
Normal (6/18 and above ) 65 60 125 76.7 
Moderate Visual impairment (6/24 – 6/60) 9 6 15 9.2 
Severe Visual Impairment (5/60 – 3/60) 6 7 13 8.0 
Very severe Visual Impairment (Blind) 
(Less than 3/60) 
9 1 10 6.1 
Total 89 74 163 100.0 
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Table 4: Visual Acuity Grouping (n=163) 
Range Male Female Total (%) 
Normal Vision (6/18 and above) 65 (73.0) 60 (81.1) 125 (76.7) 
Impaired vision (≤6/24) 24 (27.0) 14 (19.9) 38 (23.3) 
Total 89 (100.0) 74 (100.0) 163 (100.0) 
 
 
 
4.3. Risk indicators for Visual impairment: 
The association between blood sugar levels and visual impairment was not uniform in the 
categories of blood sugar levels, where a larger proportion of visual impairment was 
observed in the group of study subjects who presented with a high blood sugar level 
where it accounted for 30.3% (Table 5). However, this group, when compared to that 
which had diabetic cases presented with normal blood sugar, it was found that  there was 
no statistically significant association between presented blood sugar level and degree of 
visual impairment (Odds ratio 0.92;  95% CI: 0.30 – 2.81). 
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Table 5: Association between the Levels of sugar and Level of Vision (n=163) 
Range of Fasting 
Blood Sugar 
Impaired 
vision 
Normal 
Vision 
Total Odds ratio (95% CI) p-value 
Normal  12 (28.6) 30 (71.4) 42 1  
Impaired  16 (18.2) 72 (81.8) 88 1.80 (0.70 - 4.63) 0.1777 
High 10 (30.3) 23 (69.7) 33 0.92 (0.30 – 2.81) 0.8701 
Total 38 125 163   
 
 
Annual eye examination which is mandatory for all diabetic patients was achieved by 
only 49.1%, and there was no significant gender preponderance (Figure 1).  
 
Figure 1: Frequency of Eye examination for the past one year (n=163) 
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There was no statistically significant association between level of education and per 
annual eye examination (chi-square less than 5.0), however, a larger proportion (56.44%) 
of patients who attained a university/college qualification had reported having an eye 
check in the past year as compared to those attended 32.0% of uneducated group as 
shown in Table 6 below.  
 
Table 6: Association Between Level of Education and Eye Examination for the past 
one year (n = 163). 
 Eye check      
Education Level Yes No Total Odds Ratio p-value Chi-square 
University/College 31 (56.4) 24 (43.6) 55 0.36 (0.12 – 1.08) 0.0433 4.08 
Secondary School 12 (46.2) 14 (53.8) 26 0.55 (0.15 – 1.98) 0.3006 1.07 
Primary school 21 (52.5) 19 (47.5) 40 0.43 (0.13 – 1.36) 0.1057 2.62 
Non formal/ Other 8 (47.1) 9 (52.9) 17 0.53 (0.12 – 2.25) 0.3239 0.97 
Un-educated  8 (32.0) 17 (68.0) 25 1   
Total 88  83  163    
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Among the study participants who never went to the eye unit for eye examination, Table 
7 shows that 45 (54.2%) of them, had no prior information that eye examination was 
necessary, among them, women appears to carry a larger proportion for not being 
informed as compared to their male counterpart despite that male to female ratio was 
almost the same. Similarly, they had a higher dependency for someone to accompany 
them to the health unit, as it was observed that 3 (75.0%) of them did not go to the health 
unit for eye examination as they could not get somebody to accompany them as 
compared to only 1 male patient with the same reason. 
 
Table 7: Reasons Presented by Diabetic Patients for Failure to go for Eye 
Examination: (n = 83) 
Reasons for Failure of eye examination Male Female Total Percentage 
No need felt 16 11 27 32.5 
Not informed for eye check necessities 19 26 45 54.2 
No one to escort 1 3 4 4.8 
Other reason(s) 4 3 7 8.5 
Total 40 43 83 100.0 
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Analysis was done to find if there is any association between regular eye examination and 
individual’s level of satisfaction with services provided at study participants’ respective 
health unit. It was found that there is a relationship between failure to attend at the health 
unit for a regular annual eye examination and dissatisfaction with diabetic services 
provided at a local health unit. The results were statistically significant (Odds Ratio: 0.34; 
95% CI: 0.15 – 0.77) and p-value of 0.044 as shown in Table 8 below. 
 
Table 8: Association between eye examination and satisfaction with diabetic care 
services in the health unit (n=163) 
Eye 
examination 
DM care Service 
satisfaction 
 Total  
 No Yes   
No 13 70 83 OR: 0.34(0.15 – 0.77) 
Yes 28 52 80 p-value: 0.044 
Total 41 122 163 Chi-square: 8.09 
 
 
Among the reasons given by the study participants for dissatisfaction of diabetic 
management services as shown in Table 9 below, lack of diabetic medicine was the main 
reason which accounted for 16 (39.0%) individuals. Long waiting time to be seen by the 
doctor and cost of diabetic management were other important factors reported. In male, 
unavailability of diabetic medicine was the most striking reason for dissatisfaction, while 
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in women, the main reasons for not satisfied with diabetic care was long waiting time to 
be seen by a doctor and cost of diabetic treatment. 
 
Table 9: Frequency: Reasons for not being satisfied with Diabetic Service at Eye 
health unit (n = 41). 
  Responses Male Female Total (%) 
High Cost of Diabetic management  2 6 8 (19.5) 
Long waiting time 4 6 10 (24.4) 
Medicine not available 11 5 16 (39.0) 
Discouraged by health unit staff 2 0 2 (4.9) 
Short consultation time 0 1 1 (2.4) 
Other reasons 1 3 4 (9.8) 
Total 20 21 41 (100.0) 
 
 
 
Diabetic complications related to the eyes were found in 70 cases (42.9%) of all eligible 
diabetic cases. Analysis to determine the cause of visual impairment as related to diabetes 
mellitus as shown in Table 10 revealed that, retinopathy in both male and females 
accounted for a larger proportion among all eye complications discovered, the 
retinopathy weighed 50.0%  for all pathologies noted followed by cataract (17.1%).  
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Table 10: Frequency of Diabetic Eye Complications (n = 70). 
Eye Complications Male Female Total (%) 
Cataract 7 5 12 (17.1) 
Retinopathy 20 15 35 (50.0) 
Corneal related 1 0 1 (1.4) 
Optic nerve 1 3 4 (5.7) 
Other 8 10 18 (25.8) 
Total 37 33 70 (100.0) 
 
Residential area, as one of the risk indicators was analysed based on urban and rural set 
up of the study subjects in relationship to the presence of any eye complication as a result 
of diabetes mellitus. There was no statistical significant relationship observed (0.78 (95% 
CI: 0.36 – 1.70), p-value 0.78) as shown on Table 11.  
 
Table 11: Association between Presence of Diabetic Eye Complications and 
Residential area 
 
 Eye 
complications 
   
Residence Yes No Total (%) 95% CI 
Mkuranga Urban 51 72 123 (75.5) 0.78 (0.36 – 1.70) 
Mkuranga Rural 19 21 40 (24.5) p-value 0.50 
Total 70 93 163 (100.0)  
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Analysis to find association between the duration of diabetes mellitus from the time of 
diagnosis and visual impairment has been presented in Table 12, where it is noted that 
there is a strong relationship between the two comparable factors (Odds Ratio 0.02 (95% 
CI:0.00 – 0.13), it has been observed for those DM patients who were diagnosed within 
one year before commencement of this study, none of them was had any form of visual 
impairment, and those diagnosed between 1 and 5 years prior to this study, 15 (19.2%) 
had visual impairment, and those who had more than 5 years since diagnosis for diabetes 
mellitus was made, 57.5% of them had visual impairment.  
 
Table 12: Association between the Duration of Diabetes Mellitus from time of 
diagnosis and level of Visual acuity. (n = 163) 
Duration of DM Impaired 
vision 
Normal 
Vision 
Total Odds Ratio p-value Chi-
square 
Under 1 year 0 (0.0) 45(100.0) 45 1   
1 – 5 years 15 (19.2) 63 (80.8) 78 0.09 (0.00 – 0.66) 0.00429 8.16 
Over 5 years 23 (57.5) 17 (42.5) 40 0.02 (0.00 – 0.13) 0.00000 27.32 
Total 38  125 163    
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Prevalence of diabetic retinopathy in the study population was found to be 21.5% (Table 
10). When duration of diabetes mellitus from the time of diagnosis was compared with 
presence of retinopathy, it was observed that those who had been diagnosed with DM for 
less than one year, there was no one who was found to have retinopathy, in the group 
diagnosed between 1 year to 5 years, 19.2% of cases had diabetic retinopathy and the last 
group of those diagnosed with diabetes mellitus for more than 5 years, 20 (50.0%) of 
them were discovered to have diabetic retinopathy. The association between the duration 
of diabetes and retinopathy was significant as in Figure 2 below.  
 
Figure 2: Relationship between Duration of diabetes mellitus from the time of 
diagnosis and Presence of Diabetic retinopathy 
0
5
10
15
20
25
Less than 1 year Between 1 - 5
years
More than 5 years
Retinopathy
 
Statistical relationship between duration of DM of groups between the duration of 1 -5 
years and that of less than a year: 0.09 (CI: 0.00 – 0.66) odds 0.00429 
Relationship between duration of DM between duration of over 5 years and that of less 
than 1 year: 0.02 (0.00 – 0.17) odds 0.00000 
Adjusted odds 0.09 (95% CI: 0.01 – 0.39), p-value; 0.00012, Chi-square 14.6 
Prevalence of diabetic retinopathy 21.5% 
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When the duration of diabetes mellitus from the time of diagnosis among visual impaired 
diabetic patients was analysed in trying to find its association with development of 
diabetic eye complications, no statistical significant association was found when the 
duration categories were compared as shown in Figure 3 despite the fact that, eye 
complications were found in 37 patients (97.4%) of all diabetic patients with visual 
impairment, and there is strong association between presence of eye complications and 
visual impairment (p-value of 0.00000) . as shown on table 13 below. 
 
Figure 3: Association Between Duration of Diabetes Mellitus and Presence of Eye 
Complications among Visually Impaired Patients (n = 38). 
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The statistical relationship between duration of DM between 1 – 5 years and that of less 
than 1 year. 0.13 (0.00 – 7.51): odds ratio; 0.1607 
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The statistical relationship between the duration of DM over 5 years and that of less than 
1 year0.04 (0.00 – 3.00). odds 0.0168 
Table 13: Association Between Visual Impairment and Presence of Eye 
Complications 
 Complication No 
Complication 
Total Odds Ratio p-value 
Impaired Vision 37 1 38   
Normal Vision 33 92 125 103.15 (14.20 – 2101.36) 0.0000 
Total 70 93 163   
Chi-square: 59.90 RR: 3.69 (95% TS: 2.74 – 4.97) 
 
In the same group of visually impaired diabetic patients, when analysis was done among 
them to find the association between their level of presented blood sugar and presence of 
diabetic eye complications, no statistical significant results were obtained (Table 14).  
 
Table 14: Association Between the Level of Blood Sugar and Diabetic Eye 
Complications among Visually Impaired Cases 
Range Complication No 
Complication 
Total Odds Ratio p-value 
Normal  12 0 12 1  
Impaired  15 1 16 1.63 (0.10 – 51.23) 0.7024 
High  10 0 10 1.18 (0.00 – 50.21) 0.9095 
Total 37 1 38   
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Similarly longevity was found to carry no statistically significant association with visual 
impairment in this group of visually impaired diabetic patients (Table 15). However, it 
has been observed, that the diabetic patients with visual impairment under the age of 40 
years, carry no increased risk for developing eye complication. 
 
Table 15: Association between Age groups and presence of Diabetic Eye 
Complications among Visual Impaired cases 
Age groups in 
years 
Complication No 
Complication 
Total Odds p-value 
20 – 40 0 0 0 1  
41 - 60 22 1 23 0.09 (0.00 – 4.79) 0.06896 
61 - 80 15 0 15 0.06 (0.00 – 4.59) 0.05447 
Total 37 1 38   
 
 
 
4.4. Impact of visual impairment among diabetic patients: 
For comparison and trying to elicit association of level of visual acuity and various 
factors related to psycho-social activities of daily living, cognitive functions, behavioural 
changes and socio-economic impact of having diabetes with or without visual 
impairment, several factors were analysed and comparison was made between diabetic 
patients with visual impairment and those with normal vision. Level of visual acuity was 
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determined according to the WHO grading scale for visual impairment. The categories 
for visual level was adjusted to fit into groups of normal vision and impaired vision as 
seen in table 4 above. It is observed that there is considerable proportion of diabetic 
patients with visual impairment (45.6%) who reported that their visual impairment 
impedes various physical activities of daily living among the group of diabetic patients 
with visual impairment. This is far high when compared to the group of diabetic patients 
with normal vision, where in the later group, 11.3% reported some form of impaired 
activities of daily living. The association between visual impairment and impaired 
physical activities of daily living is statistically significant (OR: 6.57 (95% CI: 2.78 - 
15.78) as shown in Table 16. 
 
Table 16: Association between Performance of Activities of Daily Living and Level 
of Vision (n = 163) 
AODL Impaired vision Normal Vision Total (%)  
Impaired 26 (45.6) 12 (11.3) 38 (23.3)  
Normal 31 (54.4) 94 (88.7) 125 (76.7) OR: 6.57 (2.78 - 15.78) 
Total 57 (100.0) 106 (100.0) 163 (100.0) p-value: 0.00000 
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Cognitive function was assessed and compared between study participants with both 
normal and visual impairment to determine if there is any association between alteration 
of cognitive function and presence of visual impairment. The results shows that 34.2% of 
subject with visual impairment has some form of cognitive impairment as compared to 
the same participants with normal vision who had lower proportion (8.8%) for cognitive 
function impairment. The association is statistically significant as shown in Table 17. 
 
Table 17: Association between an integrity of Memory Capacity and Visual Level (n 
= 163). 
Visual Level Impaired 
Memory 
Normal Memory Total  
Impaired Vision 13 (34.2) 25 (65.8) 38   
Normal Vision 11 (8.8) 114 (91.2) 125  OR: 5.39 (1.98-14.81) 
Total 24  139  163  p-value: 0.0001 
 
 
Psychological changes among diabetic patients in Mkuranga district with normal and 
impaired vision was compared as summarised in Table 18. It was noted that there is 
statistically significant relationship between visual impairment and psychological 
instability. The data have shown that 52.6% of people with visual impairment reported to 
have a form of mental lag as compared to 10.4% of those in the same category, but with 
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normal vision. Similarly, the activities which need higher concentration were assessed 
and compared between diabetic patients with normal and impaired vision. In this 
assessment, it was noted that there is significant association between visual impairment 
and altering in attention for task oriented activities, as 27 cases (71.1%) in visual 
impairment group had altered attention as compared to only 9 (7.2%) in subject with 
normal vision. The results are shown in Table 19 and are statistically significant with a p-
value of less than 0.05. 
 
Table 18: Association between Level of Alertness and Visual Level (n = 163). 
Vision  Impaired Alertness Normal Alertness Total (%)  
Impaired 20 (52.6) 18 (47.4) 38  OR:9.57(3.75-24.82) 
Normal  13 (10.4) 112 (89.6) 125  p-value 0.0000000 
Total 33  130  163  Chi-square 32.19 
 
 
 
Table 19: Association between Activities which need mental concentration and level 
of Vision 
 
Activities 
Impaired vision Normal Vision Total (%)  
Impaired 27 (71.1) 9 (7.2) 36 (22.1) OR:31.64 (10.87 – 96.02) 
Normal  11 (28.9) 116 (92.8) 127 (77.9) P-value: 0.00000 
Total 38 (100.0) 125(100.0) 163  
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Activities related to social interactions were assessed in the two groups of normal vision 
and those with impaired vision. It was found that among those who had some sort of 
alteration in the social interaction activities, in the group of normal vision had an upper 
edge in terms of number. But overall proportion of those with vision impairment, 26 
(74.2%) of them, expressed difficulties to cope with the normal social interactions they 
had before as compared to 54 (45.8%) of those who has normal vision. Table 20 shows 
that there is strong association between visual impairment and altered social activity 
participation where the results are statistically significant with odds ratio of 3.42 (95% 
CI: 1.38 – 8.67).  
 
Table 20: Association between Interactions in Social activities and the Level of 
Vision 
 
Social 
interactions 
Vision  Total (%)  
 Impaired Normal   
Difficult in 
coping 
26 (74.2) 54 (45.8) 80 (52.3) OR: 3.42(1.38 – 8.67) 
Coping 9 (25.8) 64 (54.2) 73 (47.7) p-value: 0.0030 
Total 35 (100.0) 118 (100.0) 153 (100.0)  
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Tables 21, 22 and 23 represents the results related to the social economical impact among 
the diabetic patients with impaired vision as compared to those with normal vision. 
 
Ability for diabetic patients to support their family economically among diabetic patients 
with visual impairment, it was observed that 26 (68.4%) of the patients with visual 
impairment expressed a degree of inability to support their families, while in the category 
of diabetic patients with normal vision, 16 (33.1%) expressed similar difficulties. In 
overall assessment, it has been shown that there is statistical significant relationship on 
impaired vision and difficulties to support the family financially (Odds ratio: 0.36 (95% 
CI: 0.17 – 0.76).  
 
Table 21: Association between Ability to Support Family and the Level of Vision 
Family 
support 
Impaired 
vision 
Normal 
Vision 
Total (%)  
Difficult 26 (68.4) 16 (33.1) 42 (25.8) OR: 0.36 (0.17 – 0.76) 
No problem 12 (31.6) 109 (66.9) 121 (74.2) p-value: 0.00337 
Total 38 (100.0) 125 (100.0) 163 (100.0) Chi-square: 8.59 
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Cost for management of diabetic mellitus among the diabetic patients in Mkuranga 
district was assessed and the perception reported from diabetic patients with impaired 
vision was compared to the perception reported by diabetic patients with normal vision to 
find if there is any association on how diabetic patients perceive the cost of diabetic 
management and visual impairment. It was found that diabetic patients with visual 
impairment perceive the cost as hindrance factor for management of diabetes mellitus as 
compared to those diabetic patients with normal vision as shown on table 23 (Odds ratio: 
15.34 (95% CI: 5.67 – 43.18).  
 
Figure 22: Association between the Perception on the Cost of DM Management and 
the Level of Vision (n = 163). 
DM 
management 
cost 
Impaired 
vision 
Normal Vision Total (%)  
Difficult 31 (81.6) 28 (22.4) 59 (36.2) Chi square: 44.19 
Affordable 7 (18.4) 97 (77.6) 104 (63.8) OR: 15.34 (5.67 – 43.18) 
Total 38 (100.0) 125 (100.0)  163 (100.0) p-value 0.0000000 
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Prediction on impact for the future life while living with diabetes mellitus for diabetic 
patients living in Mkuranga district was assessed. There was a strong relationship 
between visual impairment and negative impact predictions from diabetic patients with 
visual impairment which accounted for 71.1% of all diabetic patients with visual 
impairment as compared to 18.4% to the diabetic patients with normal vision. This 
relationship is statistically significant as shown on Table 27 (Odds ratio: 13.34 (95% CI: 
5.42 – 33.51). 
 
Table 23: Association between The Impact on Future Life while living with diabetes 
mellitus and the Level of Vision (n = 163) 
Level of Impact Impaired 
vision 
Normal 
Vision 
Total (%)  
Negative Impact 27 (71.1) 23 (18.4) 50 (30.7) Chi-square: 47.41 
Positive Impact 11 (28.9) 102 (81.6) 113 (69.3) OR: 13.34(5.42– 33.51) 
Total 38 (100.0) 125 (100.0) 163 (100.0) p-value: 0.00000 
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CHAPTER FIVE 
 
DISCUSSION 
 
General overview and prevalence of visual impairment: 
This study was primarily aimed at determining the prevalence of visual impairment 
among diabetic patients attending Mkuranga District Hospital. The study was also aimed 
at assessing the severity of visual impairment cases among diabetic patients with visual 
impairment in addition to determining the socio-economic impact.  
 
The data analysed were collected from 163 diabetic patients attending Mkuranga District 
Hospital. There was no gender preponderance among the participants as the ratio between 
male and female was almost the same at 1.2:1. This is not quite different from other prior 
studies conducted, especially in developed countries, where male usually have a slightly 
higher proportion of DM patients (Danaei et al, 2009). 
The prevalence for visual impairment among diabetic patients attending Mkuranga 
District Hospital was found to be 23.3%. There is no previous similar study, which has 
been conducted in Mkuranga district. In consequence, there is no data for comparative 
purposes to help determine whether the prevalence in the area has increased or fallen. 
From a gender perspective, male diabetic patients were noted to have a higher prevalence 
rate of visual impairment than their female counterparts as they accounted for 27.0% for 
the cases as compared to 19.9% for the female patients. This observation is similar to one 
 
 
 
 
 45 
made in another study which was conducted among the Yemeni diabetic population (Al-
Akily, Bamashmus and Gunaid, 2011).  
Using the WHO classification of visual impairment severity, the study observed that in 
Mkuranga district 9.2% were classified as having moderate visual impairment, 8.0% as 
having severe visual impairment and 6.1% as very severe visual impairment (blind).   
Nevertheless, studies on the prevalence of visual impairment in diabetics in Africa are 
scarce. Using the findings drawn from the few studies, which have been conducted on the 
continent, we were able to compare with those obtained locally from the diabetic study in 
Mkuranga. This comparative analysis helped to establish that Mkuranga’s visual 
impairment prevalence is actually lower than those found in Ethiopia and South Africa 
(Teshome et al, 2004, Mash et al, 2008).  
5.2.  Risk indicators for visual impairment 
Visual impairment is a common presentation in diabetic patients. It arises when diabetic 
patients develop diabetic eye disease which is usually characterised by the presence of 
one or more diabetic eye complications.  
The duration of the DM disease, as indirect measure, was found to be associated with 
visual impairment among diabetic patients attending Mkuranga District Hospital. It was 
more obvious when the duration of DM was longer.  Those with a diabetic diagnosis of 
more than five years were found to have a stronger visual impairment (p-value 0.00000) 
than those with a diagnosis of between 1 and 5 years (p-value 0.00429). A similar 
observation was made in the systematic review and meta-analysis study by Wong and 
colleagues (2009).  In the Mkuranga study, it was also established that diabetic patients, 
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who were diagnosed to have DM for more than 5 years before the commencement of the 
study, accounted for almost two-thirds of all study population with visual impairment.  
The remaining one-third was made up of patients with a 1-5 year diagnosis prior to this 
study. Among those diagnosed with DM of less than one year, none of them suffered 
from any form of visual impairment.  
 
Furthermore, an analysis was done to determine the association between the duration of 
diabetes and the presence of eye-complications. The results confirm that there is a strong 
correlation between the two factors. The pre-determined diabetic eye complications were 
observed in 70 diabetic patients. These patients accounted for 42.9% of all the study 
participants. Similar eye-complications reported in other studies include diabetic 
retinopathy, cataract and others (Klein et al, 1984). The participants with visual 
impairment in the Mkuranga study were assessed to determine whether these 
complication increase their risk of developing visual impairment. The outcome shows 
that the study participants with complications had a 103 times likelihood of developing 
visual impairment than those who did not have any diabetic eye complication. 
 
In this study, the commonest complication noted was diabetic retinopathy. This 
accounted for 50.0% of all diabetic eye-complications as observed from the study 
participants. Other eye-complications observed include cataract (17.1%), optic 
neuropathy (5.7%) and other sub-groups, which accounted for 27.2% of the cases. The 
prevalence of diabetic retinopathy found was 21.5%, a figure which lies within the wide 
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range of diabetic retinopathy prevalence established in other studies which vary from 
9.2% to 55.4% (Levitt et al., 2004; Teshome et al., 2004; Mengesha, 2006; Gill et al., 
2008; Majaliwa et al., 2008).  The presence of retinopathy was strongly associated with 
the duration of diabetic mellitus. Indeed, the longer the duration of diabetes mellitus, the 
more likely the patient was to get diabetic retinopathy. It was also observed that patients 
with longer duration of DM faced a risk of 0.09 times (0.01 – 0.39) of the likelihood of 
developing retinopathy. This association was also observed in other studies conducted 
elsewhere in the world (Klein et al, 1984, Rotimi et al, 2003, Wong et al, 2009, Klein et 
al, 2010).    
 
Poor glycemic control is another known risk indicator for visual impairment in patients 
with diabetic mellitus. In the Mkuranga study, 121 of study participants (74.2%) were 
found with impaired blood glucose level. Subsequent analysis found that diabetic patients 
with impaired glycemic level had a visual impairment which was twofold higher than that 
of those with normal vision. This finding, however, was not statistically significant in the 
Mkuranga study, as compared to another study which was done in Nigeria (Rotimi et al, 
2003), where the association between poor glycemic control and visual impairment was 
evident as a risk indicator for developing diabetic eye-complications. Poor control of 
blood sugar carries an increased risk of development of eye-complications among 
Mkuranga diabetic population. Having three quarters of the study participants being 
found with impaired blood sugar signifies a big gap between attitude, knowledge and 
perception of diabetes mellitus among patients and healthcare providers. Certainly, this is 
an issue that needs to be looked upon.  
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5.3.  Factors behind visual impairment in patients with diabetes mellitus  
Mkuranga District diabetic patients are vulnerable to similar risk factors of developing 
visual impairment like other studies have reported in different countries (Rotimi et al, 
2003, Wong et al, 2009, Klein et al, 2010).  However, there are some specific factors 
observed which potentially pose a risk of developing diabetic eye-complications among 
the diabetic population of Mkuranga district.  
 
Lack of knowledge was observed as one of the contributory factors to poor attendance of 
mandatory annual eye-examination. Only 49.1% of the study population had had an eye-
examination within a year prior to the commencement of this study. An initial assumption 
was made to the effect that the level of one’s education among the study population had 
an influence on one’s willingness to attend the annual eye-examination on regular basis. 
This assumption was based on the belief that higher education raises the prospect of 
exposure to the knowledge about diabetes mellitus and necessity of mandatory annual 
eye-examinations. However,  it was observed in this study that the level of one’s 
education had no bearing on the diabetic patients’ going for annual eye-examinations. 
Alarmingly, it was established that more than half of the study population (54.2%) had 
not been informed about the importance of eye-examinations despite paying regular visits 
to the same health unit. Of the 45 study participants who were not informed about the 
necessity of an eye-examination by healthcare providers, 26 of them (57.8%) were 
women. The overall ratio of male to female was almost at par (1.2:1 in favour of male 
participants). In real terms, it emerged that a larger proportion of women than men was 
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not informed. This lack of knowledge tends to undermine their accessing of eye-care 
services for diabetes mellitus disease. Another reason which prevents female diabetic 
patients in Mkuranga from to attending eye-examination included having no one to escort 
them to the health facility. In this category,  three quarters of the respondents cited lack of 
somebody to escort them to the health unit for diabetic management and eye assessment 
as a reason.   
Also, 27 of the study participants (32.5%) acknowledged that at one time they had 
received advice to go for an eye-examination. However, they did not feel the urge to do 
so as they were able to see well, therefore, did not believe an eye-examination was 
necessary. And yet, during the study we realised that even the healthcare providers did 
not have full knowledge at their disposal on how to assess the eyes properly before 
making a prompt referral to an eye unit whenever a need arose.  
 
On the whole, the study established that lack of knowledge on diabetic eye disease, or 
failure to adhere to the principles of diabetes mellitus management can increase the risk 
of developing eye complications among the Mkuranga diabetic population. A similar 
knowledge discrepancy was described by Zgibor and Songer (2001) during the 
assessment of the external barriers to diabetic care. A similar outcome was established in 
the analysis done during a study in India (Venkataraman, Kannan and Mohan, 2009), 
which found insufficient knowledge in understanding diabetes mellitus among the 
diabetic patients.  
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The rural-to-urban drift has often been associated with an increased risk of acquiring non-
insulin dependent diabetes mellitus (Mennen et al., 2000). This state tends to raise the 
potential risks of developing visual impairment in subsequent years. In this research, 
72.9% of the study participants reside in urban area. However, there was no statistical 
evidence to validate the association between urban residential area and the development 
of diabetic eye-complications. In fact, the trend of acquiring Type 2 diabetes mellitus 
appears to have become more prevalent than in the past even in the rural setting of 
Mkuranga District.  
 
5.4.  Impact of visual impairment on diabetic patients  
Important factors related to daily living activities for diabetic patients with impaired 
vision and those with normal vision were compared in a bid to understand whether there 
is an impact on only those with visual impairment or in both sub-groups. The study 
outcome shows that in the sub-group of those with an impaired vision were 6.57 times 
(95% CI: 2.78 – 15.78) more likely to have daily living activities that were undermined 
by their state than the diabetic patients with a normal vision (p-value 0.00000). This 
finding has implications for the socio-economic well-being of diabetic patients in 
Mkuranga district as poverty is widespread among the Mkuranga population, and yet the 
management of diabetes mellitus is an expensive exercise.  
 
The cognitive function of participants with normal vision and those with an impaired 
vision was assessed. The findings show that the diabetic patients with visual impairment 
 
 
 
 
 51 
were 5.39 times more likely to have an impaired cognitive function than those with a 
normal vision. Similar results were obtained when the psychological wellbeing of the 
study participants was assessed. This assessment was done by comparing these two 
groups of impaired and normal vision respondents. The results revealed that the diabetic 
patients with an impaired vision were 9.57 times more likely to have psychological 
instability than those with a normal vision.  
 
Furthermore, an assessment was made to compare the after-effect of social interactions 
between diabetic patients with visual impairment and those with normal vision. The 
majority of diabetic patients with visual impairment indicated that they had to change 
their habitual social interactions after they were diagnosed with diabetes mellitus. The 
study also established that the study subjects with visual impairment were 3.42 times 
more likely to report an alteration in their social interactions than those with normal 
vision. 
 
The study also examined the socio-economic impact from different perspectives, before 
gauging how this impact affected the two study groups: those with normal and those with 
an impaired vision. Diabetic patients with a visual impairment expressed a varied degree 
of inability to meet all their financial family needs, and were 0.36 times (0.17 – 0.76) 
more likely to have financial difficulties than those with normal vision. On the same 
aspect of socio-economic impact, a cost analysis for the treatment of diabetes mellitus 
was done. This analysis was based on an individual’s ability and perception of affording 
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diabetic treatment. The group with visual impairment was 15.34 times more likely to 
perceive financial difficulties to meet the cost of managing diabetes mellitus than the 
group with normal vision. 
 
5.5.  Impact on Public health 
In this study, it was observed that the age group that was more affected by visual 
impairment belonged to individuals aged between 41 and 60. These accounted for 77.3% 
of the study population. From a gender perspective, females had a larger proportion when 
they were analysed separate from males within this same group. These females accounted 
for 83.8% of all female study participants as compared to male who represented 71.9% of 
subjects in their sub-group. This age group also happens to be the most experienced and 
most productive. Therefore, the loss of vision for such a group of people has a negative 
impact on economic growth and family support. For Mkuranga District, this development 
has much more impact, especially the issue of gender is factored in, since in this 
community, women are the ones who run and monitor day-to-day activities related to the 
wellbeing of their family. In fact, most of the household activities and fieldwork in the 
district are carried out by women.  
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CHAPTER SIX 
 
CONCLUSION AND RECOMMENDATIONS 
 
The prevalence of visual impairments among diabetic patients attending Mkuranga 
District Hospital was found to stand at 23.3%. Male diabetic patients were noted to have 
a slightly higher prevalence of visual impairment as they accounted for 27.0% of the 
cases than female diabetic patient who were found to have a prevalence of 19.9%.  When 
severity of visual impairment was assessed and graded according to the WHO criteria, it 
was observed that 9.2% of the study participants had moderate visual impairment, 8.0% 
had severe visual impairment and 6.1% had very severe visual impairment or could 
simply be classified as visually blind.  
 
It has been observed that people with visual impairment face greater negative effects in 
almost all aspects, which in turn erode the quality of their lives. The effects include 
psychosocial difficulties, cognitive function changes and increased socio-economic 
burden, thus making their lives more difficult and sometimes even unbearable. Generally, 
however, living with diabetes appears to be the greatest challenge that diabetic patients 
with visual impairment were found to face in Mkuranga. Indeed, when it came to future 
life projections, many of them expressed a numbing feeling of hopelessness, which in 
turn creates life stress, a sign of frustrations or giving up. Stress in life has a direct or 
indirect effect on increasing mortality rates. Arguably, it might also be a contributory 
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factor to an increase in the mortality rate among patients suffering from NCDs, with 
diabetes mellitus being one of then, as observed by WHO (2011).. 
 
In this study, the level of  the participants’ education did not seem to have any influence 
on their getting proper diabetic eye-care. Even when information about eye-examination 
necessity was given, still response was not adequate in diabetic patients at all levels of 
education. This finding signifies that there is a gap on the dissemination of ample 
education on diabetic eye health, or the information given to diabetic patient is too 
inadequate for them to understand the proper management of diabetic-related eye 
diseases and the importance of having regular eye-examinations. It is also possible that 
diabetic care in the area under study is supervised by people who have inadequate 
knowledge on eye-health for diabetic patients.  
 
Dealing with management of eye-complications due to diabetes mellitus alone is not the 
best option in developing countries due to a horde of factors such as unavailability of  
ample financial resources, lack of medicines, inadequate eye healthcare providers, 
unknown actual burden of diabetes mellitus, lack of diabetic knowledge and many others. 
The best way of dealing with such problems in these countries is early identification of 
diabetic eye-complications by screening especially using trained village or local health 
workers. After all, in most developing countries, this group of health workers outnumbers 
trained eye healthcare providers by far. This approach of using village health workers has 
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been successful in several countries where prevalence of diabetes mellitus has been 
known to be high (Beckham et al, 2008). 
 
Nevertheless, the best solution remains the public health approach geared towards 
preventing or eliminating risk factors behind the spread of diabetes mellitus. Since the 
risk indicators for developing diabetes mellitus and risk indicators for acquiring visual 
impairment are now known in Mkuranga district, it is advisable to conduct intense 
research to measure the true burden of diabetes in the community using a population-
based study. Such a study can help establish the true burden of diabetes mellitus and the 
anthropological determinants behind the failure among patients to attend the hospital 
diabetic eye care. Moreover, this research undertaking can help establish a cost-effective 
programme for reducing the burden of emerging non-communicable diseases. Strategies 
that Abanobi (2012) suggests for Nigeria to control Type 2 DM include the identification 
of high risk cases and launch interventions in high risk groups through community health 
education using the local government diabetic control programme. This approach can be 
of high value in Mkuranga District as well.  
Also, the current trend of scaling up investment and health system development adopted 
by many countries for the control of non-communicable diseases as sub-units is 
encouraging as it is aimed at equal systematic financial fuelling in various NCD control 
initiatives. It also strives to ensure the availability of resources for programme 
sustainability as suggested by various authors (Karim and Dac, 2012, Venkataraman et al, 
2009, Mayige et al, 2012). This approach can be adopted by Mkuranga District where 
 
 
 
 
 56 
now there is now an availability of information on eye-complications among diabetic 
patients and some of their risk indicators. 
 
In addition, I suggest that Mkuranga District Hospital establish a scientific observation 
and assessment project on what is happening before the patient decide to go to the 
hospital for diabetic treatment (pre-contact); and what is going on during the course of 
assessment and treatment within the hands of diabetic health officers (Intra-contact);  and 
finally what happens when the patient goes home after the intervention had taken place at 
the hospital (Post-contact). Such concerted efforts can highlight some of the 
anthropological challenges encountered by Mkuranga District diabetic patients. Once all 
the challenges are established during the pre-contact, intra-contact and post contact 
stages, then appropriate and effective interventions can be established. These measures 
can involve the public in general, as most of diabetic patients acquire this disease because 
of their newly-adopted lifestyles. The new incidences of DM can also be reduced by 
various means mostly through public education campaigns on diabetes mellitus. 
Furthermore, it is possible to reduce the burden of DM-related visual impairment by 
incorporating community eye-care programmes within the Ministry of Health and Social 
Work budget. Women can also be empowered through the provision of education on DM. 
Subsequently, appropriate measures instituted within the district can help reduce the risk 
of acquiring diabetes mellitus in addition to reducing the burden of visual impairment and 
its associated effects among diabetics in Mkuranga District and beyond.  
 
 
 
 
 
 
 57 
 
 
REFERENCES: 
 
 
Abanobi, O. C., (2012). Community Participation in Population-Based Non-insulin 
Dependent Diabetes Mellitus Control Program: A Paradigm. International Non 
Governmental Organisation Journal; 7 (1): 1 – 8. 
 
Agardh, E., Agardh, C. D., Hansonn, C. (1993). The Five-year Incidence of 
Blindness after Introducing a Screening Programme for Early Detection of Treatable 
Diabetic Retinopathy: Diabetes Medicine; 10: 555 – 559. 
 
Al-Akily, S. A., Bamashmus, M. A., Gunaid, A. A. (2011). Causes of Visual 
Impairment Among Yemenis With Diabetes. A Hospital-Based Study: Eastern 
Mediterranean Health Journal; 17 (11): 831 – 837. 
 
Aspray, T. J., Mugusi, F., Rashid, S., Whiting, D., Edwards, R, Alberti, K. G, Unwin, N. 
C. (2000): Essential Non-Communicable Disease Health Intervention Project: Rural and 
Urban Differences in Diabetes Prevalence in Tanzania: The Role of Obesity, Physical 
Inactivity and Urban Living. Transactions of the Royal Society of Tropical Medicine and 
Hygiene. 94: 637 – 644. 
 
 
 
 
 
 58 
Beckham, S., Bradley, S., Washburn, A., Taumua T. (2008). Diabetes Management: 
Utilizing Community Health Workers in a Hawaiian/Samoa Population. Journal of 
Health Care for the Poor and Underserved, 19 (2): 416 – 427.  
 
Boutayeb, A., Boutayeb, S. (2005). The Burden of Non-Communicable Diseases in 
Developing Countries. Internation Journal of Equity in Health; 4 (2) 4 – 12.  
 
Chand, Sadeep. (2012). Silent Killer, economic Opportunity: Rethinking Non-
Communicable Disease. Briefing Paper, Center on Golbal Health Security – Chntham 
house: January 2012; 1 – 12. 
 
Ciulla, T. A., Amador, A. G., Zinman, B. (2003). Diabetic Retinopathy and Macula 
Oedema: Pathophysiology, Screening and Novel Therapies: Diabetes Care; 26: 2653 – 
2664. 
 
Cohen, D. B., Allain, T. J., Glover, S., Chimbayo, D., Dzamalala, H., Hofland, H. W. C., 
Banda, N. P. K., Zijlstra, E. E. (2010). A Survey of the Management, Control, and 
Complications of Diabetes Mellitus in Patients Attending a Diabetes Clinic in Blantyre, 
Malawi, an Area of High HIV Prevalence: The American Journal of Tropical Medicine 
and Hygiene; 83 (3): 575 – 581.  
 
 
 
 
 
 59 
Danaei, G., Friedman, A. B., Oza, S., Murray, C. J. L., Ezzati, M. (2009). Diabetes 
Prevalence and Diagnosis in US States: Analysis of Health Surveys: Population Health 
Metrics; 7: 16.  
 
Delcourt, C., Papoz, L., Villate-Cathelineau, B., Cathelineau, G., Vauzelle-Kervroedan, 
F., CODIAB-INSERM-ZENECA Pharma Study Group (1995). Visual Impairment in 
Type 2 Diabetic Patients: Acta Ophthalmologica Scandinavica; 73 (4): 293 – 298. 
 
Diabetes Control and Complications Trial Research Group (DCCTRG), (1993). The 
Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-
Term Complications in Insulin-Dependent Diabetes Mellitus: The New England Journal 
of Medicine; 329: 977 – 986. 
 
Dunstan, D. W., Zimmet, P. Z., Welborn, T. A., de Courten, M. P., Cameron, A. J., 
Sicree, R. A., Dwyer, T., Colagiuri, S., Jolley, D., Knuiman, M., Atkins, R., Shaw, J. E. 
On Behalf of the Australia Diabetes Steering Committee. (2002). The Rising Prevalence 
of Diabetes and Impaired Glucose Tolerance. The Australian Diabetes, Obesity and 
Lifestyle Study. Diabetes Care: 25: 829 – 834. 
 
Garratt A. M., Schmidt L. J., Mackintosh A. E., Fitzpatrick R. Instruments for Diabetes: 
A Review Report From the Patient-reported Health Instruments Group (formerly the 
Patient-Assessed Health Outcomes Programme) to the Department of Health, July 2000: 
1 – 115. 
 
 
 
 
 60 
 
Gill, G., Gebrekidan, A., English, P., Wile, D., Tesfaye, S. (2008): Diabetic 
Complications and Glycemic Control in Remote North Africa. Journal of Association of 
Physicians:  101 (10): 793 – 798. 
 
Gwatkin D, Guillot M, Heuveline P. (1999): The Burden of Disease Among the Global 
Poor. The Lancet: 354: 586-589. 
 
Institute of Resource Assessment (2005): Songo Songo Gas Development and Power 
Generation Project - Wayleave Village Electrification Scheme: Socioeconomic Baseline 
Data. Dar es Salaam, Institute of Resource Assessment, University of Dar es Salaam. 
 
Keen, J., Packwood, T. (1995). Case Study Evaluation. British Medical Journal. 311: 444 
– 446. 
 
Khandekar, R., Mohammed, A. J. (2005). Visual Disabilities Among Diabetics in Oman. 
Saudi Medical Journal; 26 (5): 836 – 841. 
 
King, H, Aubert, R. E., Herman, W. H. (1998): Global burden of diabetes, 1995–2025: 
Prevalence, Numerical Estimates, and Projections. Diabetes Care 21:1414–1431. 
 
 
 
 
 
 61 
King, H., Keuky, L., Seng, S., Khun, T., Roglic, G., Pinget, M. (2005): Diabetes and 
Associated Disorders in Cambodia: Two Epidemiological Surveys. The Lancet; 366 
(9497): 1633 – 1639. 
 
Klein, R., Klein, B. E. K., Moss, S. E., Davis, M. D., DeMets, D. L. (1984). Prevalence 
and Risk of Diabetic Retinopathy When Age at Diagnosis is 30 or More Years: The 
Wisconsin Epidemiological Study of Diabetic Retinopathy: Archives of Ophthalmology; 
102: 527 – 532. 
 
Klein, R., Lee, K. E., Gangnon, R. E., Klein, B. E. K. (2010). The 25-Year Incidence of 
Visual Impairment in Type 1 Diabetes Mellitus: The Wisconsin Epidemiological Study 
of Diabetic Retinopathy: Ophthalmology; 117 (1): 63 – 70. 
 
Krishnaiah, S., Das, T., Nirmalan, P., Shamanna, B. R., Nusheti, R., Rao, G. N., Thomas, 
R. (2007). Risk Factors for Diabetic Retinopathy: Findings From The Andhra Pradesh 
Eye Disease Study: Clinical Ophthalmology; 1 (4): 475 – 482. 
 
Levitt, N. S., Bradshaw, D., Zwarenstein, M. F., Bawa, A. A., Maphumolo, S. (2004). 
Audit of Public Sector Primary Diabetes Care in Cape Town, South Africa: High 
Prevalence of Complications, Uncontrolled Hyperglycaemia and Hypertension. Diabetic 
Medicine: 24 (12): 1073 – 1077. 
 
 
 
 
 
 62 
Lewallen, S., Courtright, P. (2001) Blindness in Africa: Present Situation and Future 
Needs: British Journal of Ophthalmology; 85: 897–903. 
 
Majaliwa, E. S., Jerome Elusiyan, B. E., Adesiyun O. O., Laigong, P., Adeniran, A. K., 
Kandi, C. M., Yarhere, I., Limbe, S. M., Iughetti L. (2008): Type 1 Diabetes Mellitus in 
the African Population: Epidemiology and Management Challenges. Acta Biomedica: 79: 
255 – 259. 
 
Majaliwa, E. S., Munubhi, E., Ramaiya, K., Mpembeni, R., Sanyiwa, A., Mohn, A., 
Chiarelli, F. (2007): Survey on Acute and Chronic Complications in Children and 
Adolescents With type 1 Diabetes at Muhimbili National Hospital in Dar es Salaam, 
Tanzania. Diabetes Care. 30 (9): 2187 – 2192. 
 
Marshall, S. M., Flyvbjerg, A. (2006). Prevention and Early Detection of Vascular 
Complications of Diabetes: British Medical Journal; 333: 475 – 480. 
 
Mash, B., Powell, D., du Plessis, F., van Vuuren, U., Michalowska, M., Levitt, N. (2008). 
Screening for Diabetic Retinopathy in Primary Care With a Mobile Fundal Camera – 
Evaluation of a South African Pilot Project. South African Medical Journal: 97 (12): 
1284 – 1288. 
 
 
 
 
 
 63 
Mayige, M., Kagaruki, G., Ramaiya, K., Swai, A. (2012). Non-Communicable Diseases 
in Tanzania: A Call for Urgent Action: Tanzania Journal of Health Research; 14 (2) 1 – 
12. 
 
Mennen, L. I., Mbanya, J. C., Cade, J., Balkau, B., Sharma, S., Chungong, S., 
Cruickshanks, J. K. (2000). The habitual diet in rural and urban Cameroon: European 
Journal of Clinical Nutrition; 54, 150 – 154. 
 
Molleutze, W. F., Levitt, N. F. (2006). Diabetes Mellitus and Impaired Glucose 
Tolerance in South Africa: Ch. 10. Chronic Diseases of Life Styles in South Africa: 1995 
– 2005: South African Medical Research Council Report: 109 – 121. 
 
McLarty, D. G., Swai, A. B., Kitange, H. M., Masuki, G., Mtinangi, B. L., Kilima, P. M., 
Makene, W. J., Chuwa, L. M., Alberti, K. G. (1989). Prevalence of Diabetes and 
Impaired Glucose Tolerance in Rural Tanzania. The Lancet: 1 (8643): 871 – 875. 
 
Mengesha, A. Y. (2006). Spectrum of Eye Disorders Among Diabetes Mellitus Patients 
in Gaborone, Botswana. Tropical Doctor: 36 (2): 109 – 111. 
 
Mhando P. A., Yudkin, J. S., (1980): The Pattern of Diabetic Complications in African 
Patients in Dar es Salaam. Tropical and Geographical Medicine: 32 (4): 317 – 323. 
 
 
 
 
 
 64 
Mumba, M., Hall, A., Lewalen, S. (2008): Compliance With Eye Screening 
Examinations Among Diabetic Patients at a Tanzanian Referral Hospital. Ophthalmic 
Epidemiology: 14 (5): 306 – 310. 
 
National Bureau of Statistics (2005). Population and Housing Census: Population 
Projections. Dar es Salaam, Central Census Office, President's Office, Planning and 
Privatization. United Republic of Tanzania. 
 
National Institute of Health – USA (2011). National Diabetes Statistics. N.I.H. 
Publication number 11 – 3892; February 2011: 1 – 12. 
 
Neuhann, H. F., Warter-Neuhann, C., Lyaruu, I., Msuya, L. (2002): Diabetes Care in 
Kilimanjaro Region: Clinical Presentations and Problems of Patients of the Diabetes 
Clinic at the Regional Referral Hospital – An Inventory Before Structured Intervention. 
Diabetic Medicine. 19 (6): 509 – 513. 
 
Olivarius, N. de Fine, Siersma, V., Almind, G. J., Nielsen, N. V. (2011). Prevalence and 
Progression of Visual Impairment in Patients Newly Diagnosed With Clinical Type 2 
Diabetes: A 6-Year Follow-up Study: Bio Med Central Public Health; 11: 80 – 93. 
 
Prasad, S., Kamath, G. G., Jones, K., Clearkin, L. G., Phillips, R. P. (2001). Prevalence of 
Blindness and Visual Impairment in People With Diabetes: Eye; 15 (5): 640 – 643. 
 
 
 
 
 
 65 
Ramaiya, K. (2005): Tanzania and Diabetes - A Model for Developing Countries. British 
Medical Journal; 330 (7492): 679. 
 
Rotimi, C., Daniel, H., Zhou, J., Obisesan, A., Chen, G., Chen, Y., Amoah, A., Opoku, 
V., Acheampong, J., Agyenim-Boateng, K., Eghan, B. A., Oli, J., Okafor, G., Ofoegbu, 
E., Osotimehin, B., Abbiyesuku, F., Johnson, T., Fasanmade, O., Doumatey, A., Aje, T., 
Collins, F., Dunston, G. (2003). Prevalence and Determinants of Diabetic Retinopathy 
and Cataracts in West African Type 2 Diabetes Patients. Ethnicity and Disease: 13 (2/2): 
S110 – 117. 
 
Shaw, Z. E., Sicree, R. A., Zimmet, P. Z. (2010). Global Estimates of the Prevalence of 
Diabetes for 2010 and 2030. Diabetes Research and Clinical Practise: 87 (1): 4 – 14.  
 
Sobngwi, E., Mauvais-Jarvis, F., Vexiau, P., Mbanya, J. C., Gautier, J. F. (2001). 
Diabetes in Africans. Part 1: Epidemiology and Clinical Specificities. Diabetes and 
Metabolism. 27 (6): 628 – 634. 
 
Stefánsson, E. (2006). Prevention of Diabetic Blindness. British Journal of 
Ophthalmology: 90: 2 – 3. 
 
Stenberg, K., Chisholm, D. (2012). Resourse Needs for Addressing Non-communicable 
Disease in Low and Middle Income Countries: Current and Future Developments. WHO 
Global Heart; Vol 7 (1) 1 – 8. 
 
 
 
 
 66 
 
Tesfaye, S., Gill, G. (2011). Chronic Diabetic Complications in Africa: African Journal 
of Diabetes Medicine; 19 (1): 4 – 8. 
 
Teshome, T., Melaku, S., Bayu, S. (2004): Pattern of Retinal Diseases at a Teaching Eye 
Department, Addis Ababa, Ethiopia. Ethiopian Medical Journal: 42 (3): 185 – 193. 
 
United Nations Human Settlements Programme [cited as: UN-HABITAT] (2010). Ch. 4: 
The State of Eastern African Cities: The State of African Cities 2010: Governance, 
Inequality and Urban Land Markets; UNON / Publishing Services Section/Nairobi: 134 
– 169. 
 
United Nations (2004): World Urbanisation Prospects: The 2003 Revision. United 
Nations Publications, New York; 1 - 323. 
 
Venkataraman, K., Kannan, A., VisWanathan, M. (2012). Challenges in Diabetes 
Management With Particular Reference to India. International Journal of Diabetes in 
Developing Countries 29 (3) 103 – 109.   
 
 
 
 
 
 67 
Ward, J. D., MacKinnon, M. (1992): Diabetes Care: Quality in Health Care; 1: 260 – 
265. 
 
Wild, S., Roglic, G., Green A., Sicree, R., King, H. (2004). Global Prevalence of 
Diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care: 27: 1047 
– 1053. 
 
Williams, A. (2008). Diabetes and Visual Impairment – Identifying Needs, Ensuring Full 
Accessibility: Diabetes Voice; 53 (3): 9 – 12. 
 
Wong, T. Y., Mwamburi, M., Klein, R., Larsen M., Flynn, H., Hernandez-Medina, M., 
Ranganathan, G., Wirostko, B., Pleil, L., Mitchell, P. (2009). Rates of Progression in 
Diabetic Retinopathy During Different Time Periods: Diabetes Care; 32: 2307 -2313.  
 
World Health Orgnisation (2011). Non-Communicable Diseases Country Profiles 2011. 
WHO Press 1 – 109. 
 
Zgibor, J. C., Songer, T. J. (2001). External Barriers to Diabetes Care: Addressing 
Personal and Health System Issues: Diabetes Spectrum; 14 (1): 23 – 28. 
 
 
 
 
 
 
 
 
 68 
APPENDICES 
APPENDIX I 
Data collection tool 
 
I. General information  
 Questionnaire number  
 Health unit:  
 Date of interview  
 Name of Interviewer  
   
II. Demographic Data  
 Residential area ……………………….  
 Date of birth   
 Sex Male …………0 
Female ……….1 
 
 Marital status Unmarried ……….. 0 
Married……………1 
Cohabiting ………...2 
Widowed ………….3 
Divorced/separated ..4 
 
 
 Employment status Unemployed ………0 
Employed …………1 
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Student …………….2 
Retired ……………..3 
Peasant ……………..4 
For employed ‾↓ 
Other categories ▼Edu 
 
 
  Self employment …..1 
Government ……….2 
NGO ………………3 
Religious …………..4 
Other …………….99 
 
 
 
 
 
 Highest level of education completed None ……………..0 
University/College..1 
Secondary school....2 
Primary school…....3 
Other/ non-formal...4 
Specify ………….. 
 
 
 
III. Clinical Data   
a. Blood sugar level   
b. Visual acuity for the best eye 6/18 and above …..1 
6/24 – 6/60 ………2 
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5/60 – 3/60 ………3 
Less than 3/60 …...4 
c.  visual acuity of second eye 6/18 and above …..1 
6/24 – 6/60 ………2 
5/60 – 3/60 ………3 
Less than 3/60 …...4 
 
 
d. Is there any pathology noted No ………………0 
Yes ……………...1 
For Yes ‾↓ 
For “No” ▼ Section 
IV question number 
1. 
 
 
e. Pathology noted Cataract …………1 
Retinopathy ……..2 
Cornea related …..3 
Optic discs ………4 
Other – Specify…99 
…………………. 
 
 
 
IV. Questions and Filters: 
Q. Nº Questions Responses  
1. When were you diagnosed to have 
diabetes mellitus? 
Less than 1 year ……………1 
1 – 5 years ………………….2 
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 More than 5 years…………..3 
 
2 a. Have you had an eye check in the 
past one year? 
 
No …………………..……0 
Yes …………………..…..1 
If No ‾↓, if Yes ▼Q. No 3. 
 
 
2 b. Why? I felt that there was no need ..1 
I was not informed that I need to 
be checked for my eyes …….2 
The cost is high …………….3 
Discouraged by health care 
providers …………………..4 
Frustrated by the disease …..5 
No one to help me to see an eye 
doctor ………………………6 
Other reasons (Specify) …...99 
…………………………… 
 
 
3. Where do you attend regularly for 
diabetic treatment? 
Mkuranga Hospital …………1 
Nearby health center ………..2 
Hospital outside Mkuranga …3 
Traditional herbalist …………4 
Other (Specify) ……………99 
……………………………… 
 
 
4 a. Are you satisfied with the care you No …………………….......0  
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are receiving from the location in 
question 3 above? 
Yes ………………………..1 
If “No” ‾↓, if Yes ▼Q. No 5 
 
4 b. Why are you not satisfied? Long wait …………………..1 
Did not see the doctor ….….2 
Short consultation ………….3 
Staff unkind/rude …………...4 
Prescribed drugs not available.5 
Too expensive ……………… 6 
Other (Specify) ……………99 
……………………………. 
 
 
5. Who is assisting you financially to 
get treatment for diabetes mellitus? 
 
Government – free/subsidised.1 
Myself ………………………2 
Children …………………….3 
Parents ………………………4 
Village /community …………5 
Charity/religious organisation.6 
Other (Specify)  ……………99 
……………………………. 
 
 
6 a. From the time you were diagnosed 
to have diabetes mellitus, do you 
think it has affected your physical 
activities? 
No …………………………..0 
Yes ………………………….1 
For Yes, ‾↓, for No ▼Q. No.7 
 
6 b. Which activities have been affected? No …… 0, Yes ………. 1  
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(Tick as many as responded) 
To read 
Repair broken materials 
Clean the house 
Fetching water 
Operate machine/driving 
Field work 
Taking care of 
children/grandchildren 
Walking during the day 
Walking at night 
Cooking 
Other (Specify) ………….99 
……………………………. 
 
 
 
 
 
 
 
 
 
 
 
 
 
7 a. Do you think diabetes mellitus by 
any extent has affected you in terms 
of: Memorising events? 
If yes → 
If No ‾↓ 
 
Lost memory ……………….2 
Hardly recall …………….....1 
Recall but sometimes not 
complete……………………1 
Score 
 
 
7 b. Level of alertness? 
If yes → 
If No ‾↓ 
Sometimes impaired ….…….1 
Feel dull …………………….2 
I want to sleep all the time ….3 
 
Score 
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7 c. Task oriented concentration? 
If yes → 
If No ‾↓ 
 
Impaired but cope ……………1 
Impaired but cope with difficult.2 
Disrupted ……………………3 
Score 
 
 
7 d. Ability to communicate? 
If yes → 
If No ‾↓ 
 
Impaired ……………………1 
Feel not able to ……………...2 
Miserable …………………...3 
 
 
 
8 a. Does your friends and family know 
that you are diabetic? 
No ‾↓8b ………………..…..0 
Yes ▼8c ………………..…1 
 
 
 
 
8 b. Why? I think, they are not supposed to 
know ………………………….1 
They don’t ask me …………….2 
Afraid of stigma ……………...3 
Other reason (specify) ……….99 
………………………………. 
Go to ▼Q. 9 
 
 
 
8 c. How do they treat you now? Give me big support …………1 
No change before and after …..2 
They appear confused ………..3 
They run away from me ………4 
Other (Specify) ………………99 
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………………………………… 
9 a. Do you still attend social 
gatherings? 
If yes → 
If answer is no ‾↓ 
Increased ……………….…….1 
As before ……………………..2 
As before but with addition care.3 
Reduced ……………………….4 
Go to ▼ Q. 10 
Score 
 
 
9 b. Why I need companion ……………1 
I fear for injuries ……………..2 
It is unsafe to go out ………….3 
I am frustrated ……………….4 
Depressed ……………………5 
Other (Specify) ……………..99 
……………………………….. 
Score 
 
 
 
10. Do you think you are able to support 
your family and dependants 
I do without any problem …….1 
I do, but I need additional support 
………………………………..2 
I need support more than what I 
can give ……………………….3 
I have delegated other to take 
over …………………………..4 
I am completely dependent …..5 
 
Score 
 
 
 
 
 
11. What do you think regarding the Cheap and affordable ………….1  
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cost of diabetic treatment? 
 
Expensive but I am able to afford 
…………………………………2 
I afford with difficulty …….…..3 
I cannot afford …………………4 
 
 
 
 
12. What do you think about your future 
health with diabetes mellitus? 
Bright future ………………….1 
Probably nothing will change ...2 
Uncertainty …………………..3 
Difficult life ………………….4 
Miserable life …………………5 
Death …………………………6 
 
 
 
 
 
 
13. Do you have any suggestions 
regarding management of diabetes 
mellitus within your community? (If 
any). 
 
…………………………………... 
…………………………………. 
…………………………………. 
…………………………………. 
…………………………………. 
 
 
Thank you very much! 
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APPENDIX II. 
PARTICIPANT’S INFORMATION SHEET  
 
Dear Participant. 
Thank you for willing to hear about my research. The following is an explanation of my 
research which I am going to do and which you are my potential participant.  
This research is done as part of my study for the Masters in Public Health degree at the 
University of the Western Cape in Cape Town, South Africa. After reading the purpose 
of my research which includes your eligibility and willing to participate, anonymity and 
your rights to exit, please feel free to ask any questions regarding this research, before, 
during or after the study. My contact details and that of my supervisors are outlined at the 
end of this information sheet. We will be ready to answer or clarify anything which you 
may wish to know further. 
 
Research Title:  
Prevalence, severity, risk indicators, and impact of visual impairment among diabetic 
patients in Mkuranga District, Tanzania. 
 
Purpose of this research: 
To determine the prevalence, severity, risk indicators of visual impairment among 
diabetic patients and to evaluate its impacts on their activities of daily living and socio-
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economical consequences encountered by diabetic population with visual impairment 
attending Mkuranga district Hospital. 
At the end, this will provide baseline information, which will be useful to suggest 
appropriate measures to help diabetic patients who are attending the diabetic clinic at  
Mkuranga district hospital, whereby in a long run, its effectiveness will be used by other 
districts in Tanzania. 
 
Interview Process: 
The interview will consist of questions related to your experience and difficulties you are 
encountering on activities of daily living after being diagnosed to have diabetes mellitus. 
They will also try to elicit factors related to severity of visual impairment as a 
consequence of diabetes mellitus. 
 
Benefits of this study: 
There will be no any cost you will have to incur by participating in this study. The 
outcome of this research might not have direct benefit to you, but through the information 
you give us, will be very useful to suggest appropriate measure for the problem you are 
facing which will be presented to the public health committee in your district where they 
will be able to take necessary measures for the management of your condition. 
 
Confidentiality: 
At all times, I will keep the source of the information confidential and refer to you or 
your words by pseudonym or anonymous if you have no objections.  I shall keep the 
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contents of the above research interview confidential in the sense that the anonymity or 
pseudonym noted above will be used in all documents which refer to the interview. The 
contents will be used for the purposes referred to above, but may be used for published or 
unpublished research at a later stage without further consent. Any change from this 
agreement will be renegotiated with you. 
 
Voluntary Participation and withdrawal: 
Participation is voluntary, no body has the right to influence or force you against your 
will to participate in this research. When you agree to be interviewed, some of the 
questions may touch on issues which you may feel critical and difficult to discuss or 
giving out information. If there is anything that you prefer not to discuss please feel free 
to say so. I will not be offended and there will be no negative consequences if you would 
prefer not to answer a question. I would appreciate your guidance should I ask anything 
which you find intrusive. In case if you are feeling uncomfortable about continuing to 
participate in this research, you are free to withdraw at anytime, and there will be no 
negative consequences to you.  
 
Information about the interviewer 
Dr. E. B. Chibuga, 
P. O. Box 12114, 
Dar es Salaam. 
Tel: Mobile: 0754434950 
Email: ebchib@yahoo.co.uk 
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Should you have any questions regarding this study and your rights as a research 
participant or if you wish to report any problems you have experienced related to the 
study, please contact Dr. Ehimario Igumbor who is my supervisor at UWC.  
His contact address is:  
School of Public Health, 
University of the Western Cape, 
Private Bag X17, 
Bellville 7530, 
South Africa. 
Tel: +27 82 920 0613 (mobile); +27 21 959 3520 (office) 
Fax:+27 21 959 2872 
Email: eigumbor@uwc.ac.za  
 
In case he is out of reach, you can contact: 
Head of Department: 
Dean of the Faculty of Community and Health Sciences:  
University of the Western Cape 
Private Bag X17 
Bellville 7535         
 
This research has been approved by the University of the Western Cape’s Senate 
Research Committee and Ethics Committee. 
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APPENDIX III 
CONSENT FORM 
 
Title of Research Project: Prevalence, severity, risk indicators, and impact of visual 
impairment among diabetic patients in Mkuranga District, Tanzania. 
 
The study has been described to me in language that I understand and I freely and 
voluntarily agree to participate. My questions about the study have been answered. I 
understand that my identity will not be disclosed and that I may withdraw from the study 
without giving a reason at any time and this will not negatively affect me in any way.   
 
Participant’s name………………………..................................................... 
Participant’s signature……………………………….            
Witness……………………………….            
Date……………………… 
Should you have any questions regarding this study or wish to report any problems you 
have experienced related to the study, please contact this study coordinator: 
Study Supervisor’s Name: Dr. Ehimario Igumbor 
University of the Western Cape 
Private Bag X17, Belville 7530 
South Africa 
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Telephone: +27 21 959 3520 (office) 
Cell: +27 82 920 0613 
Fax: +27 21 959 2872 
Email: eigumbor@uwc.ac.za 
 
In case if you need further clarification, you can contact me directly through these 
contacts: 
Dr. E. B. Chibuga, 
P. O. Box 12114, 
Dar es Salaam. 
Tel: Mobile: 0754434950 
Email: ebchib@yahoo.co.uk 
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APPENDIX IV 
Data collection tool translated in Swahili language 
DODOSO 
 
I. Maelezo ya awali  
 Namba ya dodoso  
 Jina la kituo:  
 Tarehe ya mahojiano  
 Jina la anayehoji  
   
II. Taarifa za muhojiwa 
 Mahali anapoishi anayehojiwa ……………………….  
 Tarehe ya kuzaliwa   
 Jinsia Mwanaume ………0 
Mwanamke ……….1 
 
 Hali ya ndoa Hajaoa/hajaolewa…. 0 
Ameoa/ameolewa….1 
Kuishi bila ndoa rasmi.2 
Kafiwa na mwenzi.….3 
Wameachana ......... ..4 
 
 
 Hali ya kazi Hajaajiriwa ………0  
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Ameajiliwa ….……1 
Mwanafunzi …..….2 
Mstaafu …………..3 
Mkulima ……..…..4 
Ajira nyinginezo 
Kwa aliyeajiriwa ‾↓ 
                             ▼ 
 
 
 
  Amejiajiri ….........1 
Serikali ……....….2 
Taasisi isiyo ya 
kiserikali …………3 
Taasisi ya kidini …..4 
Nyingine ………….99 
 
 
 
 
 
 Kiwango cha juu cha elimu Hajasoma ………..0 
Chuo kikuu/taasisi..1 
Elimu ya sekondari.2 
Shule ya msingi…...3 
Nyingine ...............4 
Eleza ………….. 
 
 
 
III. Taarifa za afya (Clinical data)   
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a. Kiasi cha sukari kwenye damu   
b. Uwezo wa kuona kwa jicho lililo bora 6/18 au zaidi …....1 
6/24 – 6/60 ………2 
5/60 – 3/60 ………3 
Chini ya  3/60 …...4 
 
 
c. Uwezo wa kuona kwa jicho lingine 6/18 au zaidi …....1 
6/24 – 6/60 ………2 
5/60 – 3/60 ………3 
Chini ya  3/60 …...4 
 
 
d. Kuna tatizo lolote limeonekana? Hapana …………0 
Ndiyo …..……...1 
Kama jibu ni ndiyo‾↓ 
Kama ni hapana ▼ 
Nenda sehemu ya IV 
swali namba 1. 
 
 
 
e. Tatizo lililo onekana Mtoto wa jicho……1 
Retina ..........……..2 
Konea …...............3 
Mshipa wa neva …4 
Lingine, .........…99 
Eleza …………. 
 
 
 
IV. Maswali na viambata: 
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Na. Maswali Majibu  
1. Ni lini ukigundulika una ugonjwa 
wa kisukari? 
 
Chini ya mwaka mmoja ………1 
Kati ya mwaka 1 – 5 ………….2 
Zaidi ya miaka 5…………..…..3 
 
 
2 a. Uliwahi kupimwa macho kwa 
kipindi cha mwaka mmoja uliopita? 
 
Hapana …………………..…0 
Ndiyo…………………..…..1 
Kama jibu ni hapana ‾↓, na iwapo 
ni ndiyo ▼Swali Namba 3. 
 
 
2 b. Kwa nini? Sikuona sababu yoyote ............1 
Sikufahamishwa ya kuwa 
nilitakiwa kupimwa macho ..….2 
Gharama ziko juu ………….….3 
Nilikatishwa tama na watendaji 
wa afya ………………………..4 
Ugonjwa umenichanganaya …..5 
Sina mtu wa kunisaidia kwenda 
hospitali……………….………6 
Sababu nyinginezo…..............99  
Eleza …………………………… 
 
 
3. Kwa kawaida, ni wapi huwa 
unaenda kupata matibabu ya 
ugonjwa wa kisukari? 
Hospitali ya wilaya ………..…1 
Kituo cha afya kilico karibu…..2 
Hospitali nje ya  Mkuranga …..3 
Kwa mganga wa jadi …………4 
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Sehemu nyingine .......... ……99 
Eleza………………………… 
4 a. Je, unaridhika na huduma 
unayoipata katika kituo hicho cha 
afya? 
Hapana…………………….....0 
Ndiyo ………………………..1 
Hapana” ‾↓, kama ndiyo ▼Sw. 5 
 
 
4 b. Kwa nini hauridhiki? Tunasubiri huduma kwa muda 
mrefu........................................ 1 
Sipati fursa ya kumuona daktari.2 
Muda wa kumuona mganga ni 
mfupi sana …….................…….3 
Watumishi wana lugha chafu…..4 
Dawa hazipatikani.......................5 
Gharama ziko juu sana….….… 6 
Nyingine ………..............……99  
Eleza ………………………. 
 
 
5. Ni nani anayekulipia gharama za 
matibabu ya ugonjwa wa kisukari? 
 
Serikali................................1 
Mimi binafsi …….......……2 
Watoto wangu………....….3 
Wazazi wangu ……………4 
Kijiji/Jamii yangu …………5 
Taasisi ya msaada/dini.........6 
Nyingine  ………….......…99 
Eleza………………………. 
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6 a. Tangu umebainika kuwa una 
kisukari, unafiki ugonjwa huu 
umekuathiri kwa namna yoyote 
katika shughuli zako za kila siku? 
Hapana……………………..0 
Ndiyo……………………….1 
Ndiyo, ‾↓, Hapana ▼Sw. Namba 
7 
 
6 b. Shughuli zipi zimeathiriwa? 
(Jaza mengi kadiri mgonjwa 
atakavyoeleza) 
Hapana …… 0, Ndiyo ………. 1 
Kusoma 
Kutengeza vitu vilivyoharibika 
Kusafisha nyumba 
Kuchota maji 
Kuendesha chombo cha moto 
Kazi za shamba 
Kutunza watoto/wajukuu 
Kutembea wakati wa mchana 
Kutembea wakati wa usiku 
Kupika 
Nyingine ………………..99 
Eleza…………………………. 
 
 
 
 
 
 
 
 
 
 
 
 
 
7 a. Unafikiri ugonjwa wa kisukari 
umekupunguzia uwezo wa kuwa na 
kumbukumbu? 
Kama jibu ni ndiyo → 
Kama  hapana ‾↓ 
Umepoteza kabisa ………….2 
Ni vigumu kukumbuka ….....1 
Nina kumbukumbu, lakini nyakati 
nyingine inaniwia vigumu……1 
 
 
 
 
7 b. Uwezo wa kuwa makini? Kuna nyakati unapungua ……...1  
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Kama ndiyo  → 
Kama hapana ‾↓ 
Najisikia uchovu muda mwingi .2 
Nahisi kutaka kulala muda wote.3 
 
 
7 c. Uwezo wa kutimiza na kufuatilia 
majukumu ya kikazi? 
Kama ndiyo → 
Kama hapana ‾↓ 
Umepungua lakini ninamudu …1 
Umepungua lakini ninamudu kwa 
shida ...........................................2 
Umepungua………………….…3 
 
 
 
7 d. Uwezo wa kuzungumza na 
kuwasiliana na watu? 
Kama ndiyo→ 
Kama hapana ‾↓ 
Umepungua ..………..………1 
Naona sijiwezi ……………...2 
Sijiwezi kabisa ……………...3 
 
 
 
8 a. Je, marafiki na ndugu zako wanajua 
kuwa una ugonjwa wa kisukari? 
Hapana ‾↓8b …………..…..0 
Ndiyo ▼8c ……………..…1 
 
 
 
 
8 b. Kwa nini? Ninadhani hawaitajiki kujua ….1 
Hawajawahi kuniuliza ……….2 
Naogopa kujulikana na kutengwa 
…………..........................…...3 
Sababu nyingine (Eleza)..….99 
………………………………. 
Nenda ▼Sw. namba 9 
 
 
 
 
 
8 c. Unaona wanakujali namna gani? Napata msaada mkubwa ……1 
Hakuna mabadiliko yoyote…..2 
Wamechanganyikiwa ………..3 
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Wamenikimbia …............……4 
Nyingine (Eleza)  ……………99 
……………………………… 
9 a. Bado unajumuika kwenye 
mikusanyiko ya kijamii? 
Kama ndiyo → 
Kama hapana ‾↓ 
Nimeongeza ……….....…….1 
Kama hapo awali …………..2 
Kama hapo awali lakini 
ninachukua tahadhari zaidi...3 
Nimepunguza ……………..4 
Nenda ▼ Swali namba 10 
 
 
 
 
 
9 b. Kwa nini? Ninahitaji mtu wa kunisindikiza.1 
Ninaogopa kuumia……………..2 
Si salama kwenda huko ..…….3 
Nimekata tamaa…….…………4 
Nina mzongo mkubwa wa 
mawazo ....................................5 
Sababu nyingine (Eleza) ……..99 
……………………………….. 
 
 
 
 
 
 
10. Je, unafikiri unaweza kumudu 
kuitunza familia yako na 
wanaokutegemea? 
Ninaweza bila tatizo lolote …….1 
Ninaweza, lakini ninahitaji 
msaada ...........………………..2 
Ninahitaji msaada zaidi kuliko 
ninavyoweza ………………….3 
Nimewakabidhi watu wengine 
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wanisaidie……………………..4 
Sijiwezi kabisa ....................…..5 
11. Unasemaje kuhusu gharama za 
matibabu ya ugonjwa wa kisukari 
hapa nchini? 
 
Rahisi ………......................….1 
Ni ghali lakini ninamudu..……2 
Ninamudu kwa shida ……..…..3 
Ni ghali na sizimudu …………4 
 
 
 
12. Nini matarajio ya maisha yako 
ukiwa na ugonjwa wa kisukari? 
Maisha mazuri………….…….1 
Sidhani kama kuna kitu 
kitabadilika .............................2 
Sina hakika …………………..3 
Maisha magumu ……….…….4 
Maisha ya kukata tamaa………5 
Kifo …………………………6 
 
 
 
 
 
13. Je, una maoni gani kuhusu matibabu 
ya ugonjwa wa kisukari hapa 
wilayani kwako? (Kama unayo). 
 
…………………………………... 
…………………………………. 
…………………………………. 
…………………………………. 
…………………………………. 
 
 
Ninakushukuru sana! 
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APPENDIX V. 
Participant’s information sheet translated in Swahili language 
 
Ndugu mpendwa. 
Nakushukuru kwa kukubali kwako kusikiliza kuhusiana na utafiti huu. Kifuatacho ni 
maelezo yanayohusiana na utafiti wangu ambao nimepanga kuufanya ikizingatiwa ya 
kuwa wewe ni mmoja wa watu muhimu wanaoweza kushiriki.  
Utafiti huu unafanywa kwanza ukiwa sehemu ya masomo yangu ya uzamili wa fani ya 
afya ya jamii katika chuo kikuu cha Western Cape kilichopo jiji la Cape Town nchini 
Afrika Kusini. Ukishasoma na kuelewa nia na madhumuni ya utafiti wangu, na kukubali 
kushiriki ukitambua ya kuwa taarifa zako hazitatolewa kwa mtu yeyote. Pia, na haki zako 
kujitoa kwenye utafiti huu bila kuathirika kwa namna yoyote. Jisikie huru kuniuliza swali 
lolote kuhusiana na utafiti huu. Njia na anuani za mawasiliano yangu na wasimamizi 
wangu zimeorodheshwa ndani ya taarifa hii. Tutakuwa tayari kukujibu au kufafanua 
jambo lolote ambalo hutakuwa umelielewa. 
 
Jina la utafiti huu:  
Ukubwa wa tatizo, dalili za hatari na athari za matatizo ya macho kwa wagonjwa wa 
kisukari katika wilaya ya Mkuranga, Tanzania. 
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Madhumuni ya utafiti huu: 
Ukubwa wa tatizo, dalili za hatari na athari za matatizo ya macho kwa wagonjwa wa 
kisukari katika wilaya ya Mkuranga ambazo zinahusiana na suala la mahusiano na kipato 
katika shughuli za kila siku kwa wagonjwa wa kisukari ambao wamepungukiwa na 
uwezo wa kuona kutokana na ugonjwa wa kisukari. 
Mwisho wa utafiti huu, taarifa tutakazozikusanya, zitaweza kutusaidia kupata taarifa za 
awali kwa wagonjwa wa kisukari wanaohudhuria hospitali ya  Wilaya ya Mkuranga,  na 
hapo baadaye tunaweza kutoa mapendekezo ambayo yanaweza kutoa faida kwenye 
sehemu nyingine kuhusiana na matibabu ya ugonjwa wa kisukari. 
 
Mchakato wa mahojiano: 
Mahojiano yatahusu kuulizwa maswali ambayo yatalenga wewe kueleza uzoefu wako na 
matatizo ambayo unakutana nayo katika shughuli zako za kawaida katika maisha yako ya 
kila siku tangu ulipogundulika ya kuwa una ugonjwa wa kisukari. Pia maswali yatalenga 
kupata taarifa sababu ambazo zinaweza kuashiria tatizo kubwa la kuona kutokana na 
ugonjwa wa kisukari. 
 
Faida za utafiti huu: 
Hakutakuwa na gharama yoyote itakayokukuta kwa kushiriki katika utafiti huu. Matokeo 
ya utafiti huu yanaweza yasiwe na faida ya moja kwa moja kwako, bali kutokana na 
taarifa utakazotupa, zitatuwezesha kutoa mapendekezo kwenye ngazi husika katika 
kamati ya Afya ya wilaya ambao watachukua majukumu ya kutekekeleza utatuzi wa 
matatizo mnayoyapata na hivyo kuweza kukusaidia kwa siku za usoni. 
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Utunzaji wa siri: 
Kwa muda wote, taarifa zitakazokuhusu zitahifadhiwa na kama zitahitajika, basi zitapewa 
jina au neon ambalo halitakuwa na utambulisho wako. 
Matumizi ya taarifa zako hayataenda kinyume na makubaliano tuliyoyaweka kati yangu 
na wewe. Japo, kama kutakuwa na ulazima wa kuchapisha taarifa zitakazotokana na 
matokeo ya taarifa tulizozipata kutoka kwako na washiriki wengine tunaweza kuyatoa 
bila taarifa zaidi kutoka kwako. 
Kama kuna mabadiliko yoyote tunataka kuyafanya, basi tutajadiliana nawe kwanza. 
 
Ushiriki wa Hiyari 
Kushiriki katika utafiti huu ni hiyari, na wala haulazimishwi na mtu yeyote. Kama 
utakubali kushiriki katika utafiti huu, kuna baadhi ya maswali utakayoulizwa, yanaweza 
kuwa na mguso au hisia ambazo zinaweza kukufanya kushindwa kuyajibu. Iwapo 
utakuwa na hali hiyo, usisite kusema au kukataa kuyajibu kwani hakutakuwa na athari 
yoyote kwenye utafiti na hata kwako pia. 
Iwapo utaona kwa namna yoyote utafiti huu unakukwaza au kukupa shida, 
unawezakujitoa muda wowote bila sharti lolote. 
  
Maelezo ya kwangu: 
Dr. E. B. Chibuga, 
S. L. P. 12114, 
Dar es Salaam. 
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Tel: Mobile: 0754434950 
Email: ebchib@yahoo.co.uk 
 
Ikitokea una swali la ziada au tatizo lolote unalotaka kuliwasilisha kuhusiana na utafiti 
huu, Usisite kuwasiliana na msimamizi wa utafiti huu ambaye mawasiliano yake 
yameaninishwa hapo chini: 
Msimamizi wa Utafiti: Dk. Ehimario Igumbor 
University of the Western Cape 
Private Bag X17, Belville 7530, South Africa 
Simu ya ofisini: +27 21 959 3520  
Simu ya Kiganjani: +27 82 920 0613 
Nukushi: +27 21 959 2872 
Barua pepe: eigumbor@uwc.ac.za 
Iwapo msimamizi wa utafiti hataweza kupatikana kwa njia za mawasiliano zilizo 
onyeshwa hapo juu, unaweza kuwasiliana na mkuu wa idara wa chuo kama iliyoainishwa 
hapo chini. 
Mkuu wa idara: 
Kitivo cha Afya ya jamii na Sayansi:  
Chuo Kikuu cha Western Cape 
Private Bag X17 
Bellville 7535         
Utafiti huu umeidhinishwa na Chuo Kikuu cha Western Cape kutoka kwenye kamati ya 
idhini ya utafiti 
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APPENDIX VI 
Consent form translated in Swahili language 
FOMU YA IDHINI YA USHIRIKI 
Jina la shughuli ya utafiti: Ukubwa wa tatizo, dalili za hatari na athari za matatizo ya 
macho kwa wagonjwa wa kisukari katika wilaya ya Mkuranga, Tanzania. 
 
Nimeelezwa kwa kina na kwa lugha ambayo ninaifahamu vyema madhumuni ya utafiti 
huu. Nimekubali kwa hiyari yangu kuwa mshiriki katika utafiti huu. Maswali yangu 
niliyokuwa nayo kuhusu utafiti huu yamefafanuliwa na kujibiwa vyema 
Ninatambua ya kuwa taarifa zangu hazitatolewa kwa mtu yeyote. Pia ninaweza kujitoa 
katika utafiti huu wakati wowote kutokana na sababu yoyote ambayo si lazima kuieleza. 
Kutokana na hili ninatambua ya kuwa ushiriki wangu utakapokoma kwa sababu yoyote 
ile, sitaathirika kwa namna yoyote ile. 
 
Jina la mshiriki………………………....................................................................... 
Sahihi  ya Mshiriki……………………………….            
Shahidi……………………………….            
Tarehe……………………… 
Ikitokea una swali la ziada au tatizo lolote unalotaka kuliwasilisha kuhusiana na utafiti 
huu, Usisite kuwasiliana na msimamizi wa utafiti huu ambaye mawasiliano yake 
yameaninishwa hapo chini: 
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Msimamizi wa Utafiti: Dk. Ehimario Igumbor 
University of the Western Cape 
Private Bag X17, Belville 7530 
South Africa 
Simu ya ofisini: +27 21 959 3520  
Simu ya Kiganjani: +27 82 920 0613 
Nukushi: +27 21 959 2872 
Barua pepe: eigumbor@uwc.ac.za 
 
Iwapo utahitaji maelezo zaidi, Tafadhali wasiliana nami kupitia anuani iliyoainishwa hapo 
chini. 
Dk. E. B. Chibuga, 
S. L. P. 12114, 
Dar es Salaam. 
Simu ya Kiganjani: 0754434950 
Email: ebchib@yahoo.co.uk 
 
 
 
 
 
